{"gene":"REV1","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":1996,"finding":"Yeast Rev1 protein has a deoxycytidyl transferase (dCMP transferase) activity, transferring a dCMP residue from dCTP to the 3' end of a DNA primer in a template-dependent reaction. Efficient transfer occurs opposite a template abasic site, and approximately 20% transfer occurs opposite template guanine. The inserted cytosine opposite an abasic site produces a terminus efficiently extended by Pol-zeta but not Pol-alpha.","method":"In vitro biochemical assay (dCMP transferase activity assay with purified protein)","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro enzymatic assay with purified protein, foundational paper replicated by multiple subsequent studies","pmids":["8751446"],"is_preprint":false},{"year":1999,"finding":"Human REV1 protein is a dCMP transferase that specifically inserts a dCMP residue opposite a template G, and efficiently inserts dCMP opposite template AP (apurinic/apyrimidinic) sites and uracil residues.","method":"In vitro biochemical assay with purified recombinant human REV1 protein","journal":"Nucleic Acids Research","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro enzymatic characterization of purified human protein, replicated by multiple subsequent studies","pmids":["10536157"],"is_preprint":false},{"year":2001,"finding":"Yeast Rev1 is a G template-specific DNA polymerase: it specifically inserts a C residue opposite template G, and is approximately 25-, 40-, and 400-fold less efficient at inserting C opposite an abasic site, O6-methylguanine, and 8-oxoguanine, respectively. Rev1 has low processivity (~1.6 nucleotides per binding event).","method":"Steady-state kinetic analysis of nucleotide incorporation by purified yeast Rev1","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — rigorous steady-state kinetics with purified protein, multiple substrates tested","pmids":["11850424"],"is_preprint":false},{"year":2001,"finding":"In AP site bypass, Rev1's predominant role is likely structural rather than catalytic insertion; the combined action of Pol-delta (inserting A opposite AP site) and Pol-zeta (extending) constitutes the major bypass pathway, with Rev1 and Pol-eta contributing to insertion of other nucleotides at lower frequency.","method":"Genetic epistasis analysis combined with in vitro reconstitution and steady-state kinetics","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — combined in vitro reconstitution, kinetics, and genetic analysis in yeast","pmids":["11316789"],"is_preprint":false},{"year":2001,"finding":"The deoxycytidyl transferase activity of human REV1 is associated with its conserved polymerase domain; deletion and point mutation analysis demonstrated that the domain required for dCMP transferase and DNA binding activities resides within the conserved Y-family polymerase domain.","method":"Deletion and point mutation analysis of human REV1S protein, in vitro transferase assay","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis combined with in vitro enzymatic assay, single lab","pmids":["11278384"],"is_preprint":false},{"year":2002,"finding":"Human REV1 is required for UV-induced mutagenesis; cells with reduced hREV1 mRNA via antisense expression show significantly lower frequencies of UV-induced 6-thioguanine-resistant mutants without affecting cytotoxic sensitivity.","method":"Antisense RNA knockdown in human cells, clonogenic survival and mutation frequency assays","journal":"PNAS","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional loss-of-function with defined mutational phenotype readout, single lab","pmids":["10760286"],"is_preprint":false},{"year":2003,"finding":"Mouse Rev1 physically associates with Pol-kappa, Pol-iota, Pol-eta, and Rev7 (subunit of Pol-zeta), and each of these proteins binds to the same ~100 amino acid C-terminal region of Rev1. Rev7 competes directly with Pol-kappa for binding to the Rev1 C-terminus. The DNA polymerase activity of Rev1 and Pol-kappa is unaffected when they form a complex.","method":"Co-immunoprecipitation, GST pulldown, in vitro primer extension assay","journal":"EMBO Journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal pulldowns identifying specific binding domain, competition assay, multiple interacting partners confirmed, replicated by subsequent structural studies","pmids":["14657033"],"is_preprint":false},{"year":2003,"finding":"Rev1-deficient DT40 cells grow slowly, are sensitive to a wide range of DNA-damaging agents, and show markedly reduced non-templated immunoglobulin gene mutation (translesion bypass). UV exposure causes chromosome breakage in Rev1-deficient cells. Homologous recombination (sister chromatid exchange and gene conversion) is unaffected.","method":"Gene disruption in DT40 cells, clonogenic survival, SCE assay, Ig gene mutation analysis, chromosome analysis","journal":"EMBO Journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean gene knockout with multiple orthogonal phenotypic readouts","pmids":["12660171"],"is_preprint":false},{"year":2003,"finding":"Human REV1 and REV7 proteins form a stable heterodimer in solution. REV7 does not influence the stability, substrate specificity, or kinetic parameters of the transferase reactions of REV1 in contrast to the stimulatory effect of yeast Rev7 on Rev3.","method":"Purification of REV1-REV7 complex, biochemical analysis of transferase kinetics","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — purified complex with biochemical characterization, single lab","pmids":["12529368"],"is_preprint":false},{"year":2004,"finding":"Rev1 efficiently incorporates C opposite the N2-propano-2'-deoxyguanosine (gamma-HOPdG) minor-groove adduct, from which Pol-zeta subsequently extends, completing error-free bypass. This supports a role for Rev1's DNA synthetic activity in bypassing N2-guanine minor-groove adducts by not contacting the DNA minor groove.","method":"In vitro primer extension assay with purified yeast Rev1 and Pol-zeta on adduct-containing templates","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted two-polymerase bypass assay with specific adduct, single lab","pmids":["15282292"],"is_preprint":false},{"year":2005,"finding":"Crystal structure of yeast Rev1 bound to template G and incoming dCTP reveals that the polymerase dictates nucleotide identity via a protein-template mechanism: template G is evicted from the DNA helix and makes hydrogen bonds with a segment of Rev1, while incoming dCTP pairs with an arginine residue (Arg324) rather than the templating base.","method":"X-ray crystallography (crystal structure of ternary complex)","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with mechanistic validation, foundational structural paper widely cited","pmids":["16195463"],"is_preprint":false},{"year":2005,"finding":"Vertebrate DNA damage tolerance requires the C-terminus of REV1, which mediates interactions with PCNA, but does not require the BRCT domain or the catalytic transferase activity. A region adjacent to the polymerase-interacting domain mediates interaction with PCNA.","method":"Domain deletion/mutation analysis in avian DT40 cells, survival assays, co-immunoprecipitation","journal":"Nucleic Acids Research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple domain mutants tested in functional cellular assays with protein interaction data","pmids":["15741181"],"is_preprint":false},{"year":2005,"finding":"Ubiquitinated PCNA (monoubiquitinated at Lys-164 by Rad6/Rad18) specifically activates Rev1 (and Pol-eta) for translesion synthesis in vitro, while DNA polymerase activity of Pol-zeta remains unaffected by PCNA ubiquitination.","method":"Robust in vitro ubiquitination system for yeast PCNA, in vitro TLS assay with ubiquitinated PCNA","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted in vitro system with purified components, direct activity measurement","pmids":["16344468"],"is_preprint":false},{"year":2005,"finding":"The yeast Rev1 PAD (polymerase-associated domain) mediates binding to Rev7 (accessory subunit of Pol-zeta), forming a stable Rev1-Rev7 complex that co-purifies. This reveals a novel role for the PAD in protein-protein interactions.","method":"Co-purification, co-immunoprecipitation from yeast","journal":"Molecular and Cellular Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-purification and co-IP demonstrating stable complex, single lab","pmids":["16227619"],"is_preprint":false},{"year":2006,"finding":"Rev1 physically associates with Pol-zeta through its C-terminus binding to the Rev3 polymerase domain. A rev1 mutant lacking the C-terminal 72 residues (inactivating Rev3 interaction) shows the same UV sensitivity and loss of UV-induced mutagenesis as rev1Δ. Rev1 binding to Pol-zeta enhances Pol-zeta's proficiency for extending mismatched primer termini and primers opposite DNA lesions.","method":"Yeast two-hybrid, co-immunoprecipitation from yeast, in vitro primer extension assay, UV survival and mutagenesis assays","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (Y2H, Co-IP, in vitro biochemistry, genetics), single lab but comprehensive","pmids":["17030609"],"is_preprint":false},{"year":2006,"finding":"Mouse REV1 binds directly to PCNA, and monoubiquitylation of PCNA enhances this interaction. The BRCT domain of REV1 is required for this interaction and for targeting REV1 to replication foci in unirradiated cells. Deletion or mutational inactivation of the BRCT domain abolishes REV1 targeting to replication foci in unirradiated cells (but not UV-irradiated cells) and is required for cell survival and DNA damage-induced mutagenesis in vivo.","method":"Co-immunoprecipitation, live-cell imaging of replication foci, genetic complementation in DT40 cells and yeast","journal":"Molecular Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods across multiple cell systems, direct protein interaction and localization with functional readout","pmids":["16857592"],"is_preprint":false},{"year":2006,"finding":"Mouse REV1 physically interacts with ubiquitin via ubiquitin-binding motifs (UBMs) located at the C-terminus of REV1. These UBMs mediate enhanced association between monoubiquitylated PCNA and REV1 and are required for UV-induced REV1 localization to replication foci, DNA damage tolerance, and damage-induced mutagenesis in vivo.","method":"Yeast two-hybrid, GST pulldown assay, cellular localization (foci assay), survival and mutagenesis assays","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple methods (Y2H, pulldown, cellular localization, functional assays), domain mapping with mutagenesis","pmids":["16982685"],"is_preprint":false},{"year":2006,"finding":"S. cerevisiae Rev1 protein levels are subject to cell cycle control, being approximately 50-fold higher in G2/M than in G1/S phase. This cell cycle regulation is physiologically relevant: a rev1Δ strain shows differential survival after UV irradiation depending on the cell cycle stage at which UV is applied.","method":"Protein level measurement by western blot across cell cycle stages, UV survival assays at defined cell cycle stages","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct protein quantification across cell cycle with functional UV survival validation","pmids":["16751278"],"is_preprint":false},{"year":2006,"finding":"Yeast Rev1 is a phosphoprotein whose phosphorylation level is cell cycle regulated (unphosphorylated in G1, phosphorylated in S phase, hyper-phosphorylated in mitosis) and is further hyper-phosphorylated in response to DNA damage. Rev1 binds to chromosomes throughout the cell cycle in a MEC1-dependent manner, and phosphorylation does not modulate chromosome binding.","method":"Western blot (phosphoprotein analysis), chromosome spreading technique, genetic analysis with mec1 mutant","journal":"DNA Repair","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct phosphorylation analysis with chromosome binding experiment, but functional consequence of phosphorylation not resolved","pmids":["17035102"],"is_preprint":false},{"year":2006,"finding":"Rev1 is required for efficient UV-induced mutagenesis in human cells; ribozyme-mediated reduction of REV1 mRNA (up to 90%) reduces UV-induced HPRT mutant frequency by up to 75% without affecting cytotoxic UV sensitivity.","method":"Ribozyme knockdown of REV1 mRNA in human cells, clonogenic survival, mutation frequency at HPRT locus","journal":"Nucleic Acids Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional knockdown with specific mutational readout, single lab","pmids":["12930947"],"is_preprint":false},{"year":2006,"finding":"The yeast Rev1 C-terminus mediates interactions with Rev7 via both the PAD region and the extreme C-terminus and BRCT region. Elevated levels of the Rev1 C-terminus confer a dominant-negative effect on viability and induced mutagenesis after DNA damage, dependent on REV7.","method":"Co-immunoprecipitation from yeast crude extracts, dominant-negative overexpression assay, genetic analysis","journal":"Molecular and Cellular Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus dominant-negative genetics, single lab","pmids":["16923957"],"is_preprint":false},{"year":2007,"finding":"A ubiquitin-binding motif in the C-terminus of yeast Rev1 (residues L821, P822, I825) mediates functional interaction with the ubiquitin moiety of monoubiquitinated PCNA. Point mutations L821A,P822A,I825A abolish this interaction in vitro and strongly attenuate damage-induced mutagenesis in vivo.","method":"Mutational analysis of Rev1, in vitro binding assay with ubiquitinated PCNA, in vivo mutagenesis assay","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — active-site-equivalent mutagenesis combined with in vitro binding and in vivo functional validation, single lab","pmids":["17517887"],"is_preprint":false},{"year":2007,"finding":"Human REV1 accumulates at UV-irradiated areas of nuclei in cells expressing Pol-eta but not in Pol-eta-deficient XP-V cells. The Pol-eta–REV1 interaction (via FF residues in Pol-eta) is required for REV1 nuclear accumulation at UV damage sites and for suppression of spontaneous mutations, but not for accurate TLS of UV lesions.","method":"Immunofluorescence, complementation of XP-V cells with Pol-eta mutants, mutation frequency assay","journal":"DNA Repair","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct localization experiment with functional consequence, specific mutant rescue experiments","pmids":["19157994"],"is_preprint":false},{"year":2008,"finding":"TLS at stalled replication forks in DT40 cells requires both the translesion polymerase-interaction domain and ubiquitin-binding domain in the REV1 C-terminus. PCNA ubiquitination is not required for maintaining normal fork progression on damaged DNA but is essential for filling postreplicative gaps. Thus, PCNA ubiquitination and REV1 play distinct, temporally separated roles in DNA damage bypass.","method":"Gene disruption and domain deletion/mutation analysis in DT40 cells, DNA fiber assay for fork progression, genetic epistasis","journal":"Molecular Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple domain mutants with mechanistic dissection across two bypass modes, clean genetic system","pmids":["18498753"],"is_preprint":false},{"year":2008,"finding":"The Fanconi anemia (FA) core complex is required for efficient assembly of Rev1 nuclear foci (independently of FANCD2, FANCI, and PCNA monoubiquitination) and for efficient spontaneous and UV-induced point mutagenesis. Rev1 is required downstream of the FA core complex to prevent chromosomal aberrations caused by DNA crosslinkers.","method":"Complementation analysis in FA-deficient cells, immunofluorescence for Rev1 foci, mutation frequency assay, chromosomal aberration analysis","journal":"DNA Repair","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — foci assembly and functional assays, genetic epistasis, single lab","pmids":["18448394"],"is_preprint":false},{"year":2008,"finding":"Yeast Rev1 protein interacts with yeast Pol-eta through the Rev1 polymerase-associated domain (PAD), not the C-terminus as in humans. This complex formation enhances the DNA synthesis activity of Rev1.","method":"Co-immunoprecipitation, in vitro DNA synthesis assay, domain deletion analysis","journal":"Molecular and Cellular Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with domain mapping and in vitro activity assay, single lab","pmids":["17875922"],"is_preprint":false},{"year":2008,"finding":"Human REV1 inserts dCTP with similar catalytic efficiency (kcat/Km) opposite template G and N2-alkylguanine adducts of increasing bulk (up to N2-BPG) but is severely inhibited by O6-alkylguanine adducts. REV1 binds N2-BPG-adducted DNA ~3-fold more tightly than unmodified G-containing DNA, and the rate-limiting step is likely product release rather than chemistry opposite N2-BPG.","method":"Steady-state and pre-steady-state kinetics, elemental effect assay with purified recombinant human REV1","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — detailed kinetic characterization with multiple substrates and pre-steady-state analysis, single lab","pmids":["18591245"],"is_preprint":false},{"year":2008,"finding":"Crystal structure of yeast Rev1 in ternary complex with DNA containing an abasic (AP) lesion and dCTP reveals that the abasic lesion is driven to an extrahelical position (similar to template G) and C incorporation is mediated by the conserved Arg324 (surrogate arginine), demonstrating the same protein-template mechanism for AP site bypass.","method":"X-ray crystallography of ternary Rev1-DNA(AP)-dCTP complex","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure of ternary complex at AP site, mechanistically confirming protein-template mechanism for a second substrate","pmids":["18275815"],"is_preprint":false},{"year":2008,"finding":"The Rev1 BRCT domain of mammalian cells plays a role in early (S-phase-associated) mutagenic TLS: cells with a BRCT domain deletion are deficient in the early DNA damage bypass pathway and show reduced UV-induced mutagenesis. Rev1-deficient cells show defects in both early and late bypass pathways, with persistent gaps causing G2 arrest.","method":"Targeted deletion of BRCT domain in mouse embryonic fibroblasts, DNA replication analysis, cell cycle analysis","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — domain-specific deletion versus full knockout comparison with mechanistic pathway dissection","pmids":["19332561"],"is_preprint":false},{"year":2009,"finding":"A novel REV1-interacting region (RIR) motif containing two consecutive phenylalanines (FF motif, consensus x-x-x-F-F-y-y-y-y) present in Pol-kappa, Pol-iota, and Pol-eta is essential for binding to REV1 C-terminus. A Pol-kappa mutant lacking REV1-binding activity fails to complement genotoxin sensitivity of Polk-null cells.","method":"Yeast two-hybrid, pulldown assay, sequence alignment, functional complementation in Polk-null MEFs","journal":"Genes to Cells","confidence":"High","confidence_rationale":"Tier 2 / Strong — mutagenesis defining FF motif with in vivo functional validation, key motif conserved across polymerases","pmids":["19170759"],"is_preprint":false},{"year":2009,"finding":"Yeast Rev1 promotes complex formation of Pol-zeta with the Pol32 subunit of Pol-delta: Pol32 physically interacts with Rev1 but does not directly bind Pol-zeta, and can bind the Rev1-Pol-zeta complex through Rev1. Pol32 binding does not stimulate DNA synthesis by Rev1 or Pol-zeta in this complex.","method":"Co-immunoprecipitation, in vitro pull-down, in vitro DNA synthesis assay with reconstituted complexes","journal":"PNAS","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and in vitro reconstitution establishing protein interactions, single lab","pmids":["19487673"],"is_preprint":false},{"year":2009,"finding":"Crystal structure of human REV1 ternary complex reveals conservation of the protein-template mechanism from yeast: template G is evicted, incoming dCTP pairs with surrogate arginine. Human REV1 has two unique inserts (I1 and I2): I1 extends >20 Å from the active site (potential platform for protein-protein interactions) and I2 acts as a flap on the hydrophobic pocket accommodating template G.","method":"X-ray crystallography of human REV1 ternary complex","journal":"Journal of Molecular Biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure of human REV1 ternary complex, mechanistic conservation and novel structural features identified","pmids":["19464298"],"is_preprint":false},{"year":2009,"finding":"Mec1 (ATR homolog) promotes association of the Pol-zeta/Rev1 complex with double-strand breaks (DSBs) through Mec1-dependent phosphorylation. Rev1 plays a non-catalytic role in this DSB association. Rev1 association with DSBs does not require Rad24, nor Rad6-Rad18-mediated PCNA ubiquitination.","method":"Chromatin immunoprecipitation (ChIP) at defined DSBs in yeast, genetic analysis","journal":"Current Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP assay with genetic dissection of requirements, single lab","pmids":["16546083"],"is_preprint":false},{"year":2009,"finding":"Crystal structure of human REV7 in complex with a REV3 fragment reveals the mechanism of REV7-REV3 interaction. The REV7-REV3 structural interface creates a binding site for REV1, explaining how REV7 acts as an adaptor protein to recruit Pol-zeta to lesion sites.","method":"X-ray crystallography of REV7-REV3 fragment complex, biochemical interaction analysis","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure with structural basis for protein interactions defined","pmids":["20164194"],"is_preprint":false},{"year":2009,"finding":"Human Rev1 disrupts G-quadruplex (G4) DNA structures in vitro and prevents refolding. hRev1 binds G4 DNA substrates with 4-15-fold lower Kd than non-G4 DNA. Nucleotidyl transfer activity is not necessary for G4 unfolding. Rev1 can promote fork progression by dislodging tetrad guanines or preventing refolding.","method":"Fluorescence-based G4 disruption assay, binding affinity measurement (Kd), pre-steady-state kinetics","journal":"Nucleic Acids Research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro binding and unfolding assays with kinetic analysis, mutagenesis to separate catalytic from structural activity","pmids":["24366879"],"is_preprint":false},{"year":2010,"finding":"The UBM of S. cerevisiae Rev1 (second UBM) binds ubiquitin at the hydrophobic surface centered at L8 (not I44) of ubiquitin. Only the second UBM of yeast Rev1 is functional and is essential for Rev1-dependent cell survival and mutagenesis. Mutations disrupting UBM-ubiquitin interaction impair Rev1-mediated DNA damage tolerance in vivo.","method":"NMR structure of UBM-ubiquitin complex, mutagenesis of ubiquitin binding interface, in vivo mutagenesis and survival assays","journal":"Molecular Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — NMR structure combined with mutagenesis and in vivo functional validation","pmids":["20159559"],"is_preprint":false},{"year":2010,"finding":"Rev1's DNA polymerase catalytic activity is biologically significant in vivo for resistance to 4-NQO (which causes N2-dG adducts) but not to UV or cisplatin. The catalytic activity is more critical when error-free tolerance (Mms2 pathway) is disrupted.","method":"Catalytic dead Rev1 mutant in yeast, survival assays, mutation frequency assays with defined genotoxins","journal":"Genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — defined catalytic mutant with substrate-specific functional dissection, single lab","pmids":["20980236"],"is_preprint":false},{"year":2010,"finding":"Crystal structure of yeast Rev1 in ternary complex with AP site-containing DNA and dCTP shows the abasic lesion in extrahelical position with C incorporation mediated by conserved Arg324, establishing a unified protein-template mechanism for both template G and AP site bypass.","method":"X-ray crystallography of ternary complex","journal":"Journal of Molecular Biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure with direct mechanistic insight, single lab","pmids":["21167175"],"is_preprint":false},{"year":2011,"finding":"The Rev1-PCNA interaction occurs at a non-canonical binding site near the monomer-monomer interface of the PCNA trimer (via the Rev1 PAD domain), which is the same novel interface used by Pol-zeta. The pol30-113 mutation at this interface specifically disrupts the Rev1/Pol-zeta-dependent TLS pathway.","method":"GST pull-down, affinity bead pull-down, gel filtration, genetic epistasis analysis","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical methods identifying non-canonical PCNA binding with genetic validation, single lab","pmids":["21799021"],"is_preprint":false},{"year":2011,"finding":"The BRCT region of Rev1 (via an extra α-helix N-terminal to the BRCT domain) specifically binds 5'-phosphorylated recessed primer-template junctions. Rev1 also binds recessed 3' primer-template junctions. These dual DNA binding characteristics are proposed to mediate recruitment of Rev1 downstream of stalled forks.","method":"In vitro DNA binding assays with purified mouse and yeast Rev1, domain deletions","journal":"DNA Repair","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding assays with domain analysis, single lab","pmids":["21752727"],"is_preprint":false},{"year":2011,"finding":"The dCMP transferase catalytic activity of Rev1 is biologically relevant and required specifically for dCMP insertion during bypass of endogenously generated AP sites (from uracil excision) in yeast chromosomal DNA. Loss of Rev1 catalytic activity allows insertion of dGMP or dTMP, indicating that Rev1 catalysis is the primary determinant of C insertion opposite AP sites in vivo.","method":"Frameshift- and nonsense-reversion assays in yeast using catalytic-dead Rev1 mutant","journal":"DNA Repair","confidence":"High","confidence_rationale":"Tier 2 / Strong — sensitive in vivo genetic assay with catalytic mutant, two orthogonal reversion assays, single lab","pmids":["22024240"],"is_preprint":false},{"year":2011,"finding":"Human REV1, REV3, and REV7 interact in vivo (by co-immunoprecipitation) and together promote homologous recombination repair of DSBs. REV1, REV3, or REV7-depleted cells show increased chromosomal aberrations, residual DSBs, and defects in HR repair after ionizing radiation. Pol-eta and RAD18-dependent PCNA monoubiquitination are not required for this DSB repair function.","method":"Co-immunoprecipitation, siRNA knockdown, chromosomal aberration analysis, γH2AX foci, HR assay","journal":"Nucleic Acids Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple knockdowns with orthogonal readouts establishing HR role, single lab","pmids":["21926160"],"is_preprint":false},{"year":2012,"finding":"FAAP20, an integral subunit of the FA core complex, contains a UBZ4 domain that binds monoubiquitinated Rev1. FAAP20 binding stabilizes Rev1 nuclear foci and promotes interaction of the FA core with PCNA-Rev1 DNA damage bypass complexes. This provides a mechanistic link between the FA core complex and TLS polymerase activity.","method":"Identification of FAAP20 as FA core component, co-immunoprecipitation, domain analysis, immunofluorescence for Rev1 foci","journal":"Nature Structural & Molecular Biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP, domain analysis, direct interaction characterization with functional consequence (foci stability), single lab but comprehensive","pmids":["22266823"],"is_preprint":false},{"year":2012,"finding":"Crystal structure of the quaternary translesion polymerase complex consisting of the Rev1 CTD, heterodimeric Pol-zeta (Rev7/Rev3-RBM), and Pol-kappa RIR reveals that the Rev1 CTD serves as a scaffold with two distinct surfaces: one for Rev7 binding (at α2-α3 loop and α3) and one for RIR binding (creating a hydrophobic cavity for FF residues). This provides the molecular basis for Rev1 as a scaffold bridging insertion and extension polymerases.","method":"Protein purification, X-ray crystallography, yeast two-hybrid to validate interface residues","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure of quaternary complex with biochemical validation of interface","pmids":["22859295"],"is_preprint":false},{"year":2012,"finding":"Crystal structure of human REV1 CTD-REV7-REV3 fragment ternary complex reveals that the Rev1 CTD adopts a four-helix bundle interacting with REV7 via a conserved linker between helices 2 and 3, at a site distinct from the Pol-eta/kappa binding site. REV7 acts as an adaptor recruiting Pol-zeta to stalled forks via Rev1-REV7 interaction.","method":"X-ray crystallography, co-immunoprecipitation, cellular survival assays","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with interface distinct from previously known binding surface, functional validation","pmids":["22859296"],"is_preprint":false},{"year":2012,"finding":"NMR solution structure of mouse Rev1 CTD reveals an atypical four-helix bundle. Two distinct surfaces of the Rev1 CTD mediate Rev7 binding (centered at α2-α3 loop and N-terminal α3) and Pol-kappa RIR binding (FF residues binding in a deep hydrophobic cavity). Binding of Pol-kappa RIR induces folding of the disordered RIR into a three-turn α-helix and induces formation of a β-hairpin in the Rev1 CTD N-terminal loop.","method":"NMR solution structure determination, yeast two-hybrid, binding affinity measurements","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — NMR structure with biochemical validation of two distinct binding interfaces","pmids":["22700975"],"is_preprint":false},{"year":2012,"finding":"NMR structure of human Rev1 CTD and its complex with Pol-eta RIR shows the four-helix bundle with β-hairpin; free Rev1-CT and the Rev1-CT/Pol-eta-RIR complex exhibit μs-ms conformational dynamics at the RIR binding site that may facilitate polymerase exchange.","method":"NMR structure determination, NMR spin-relaxation and relaxation dispersion measurements","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure with dynamic characterization, single lab","pmids":["22691049"],"is_preprint":false},{"year":2012,"finding":"Rev1 directly interacts with Ung (uracil DNA glycosylase) and targets Ung to switch regions during class switch recombination (CSR) in an AID-dependent manner. Rev1-deficient B cells show reduced Ung recruitment to S regions, decreased DNA-dU glycosylation, and reduced CSR. Rescue of CSR by catalytically inactive Rev1 shows this function is mediated by Rev1 scaffolding, not enzymatic activity.","method":"Co-immunoprecipitation, ChIP, CSR assays in Rev1-/- B cells, complementation with catalytic mutant","journal":"Cell Reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP identifying novel binding partner, functional rescue distinguishing catalytic vs. scaffolding role","pmids":["23140944"],"is_preprint":false},{"year":2012,"finding":"Rev1 is required for efficient point mutagenesis (insertion/deletion) at BPDE-dG in mammalian cells, specifically for mutagenic TLS. The Rev1 C-terminus is required; yeast and mammalian three-hybrid assays confirmed REV7 mediates REV3-Rev1 C-terminus interaction, supporting Rev1 recruiting Pol-zeta through REV7.","method":"Single lesion plasmid TLS assay in Rev1-/- MEFs, complementation with C-terminal deletion mutant, yeast/mammalian three-hybrid assay","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — functional TLS assay with specific mutants and interaction mapping in multiple systems","pmids":["22303021"],"is_preprint":false},{"year":2012,"finding":"REV7 is required for APC/CDH1- and APC/CDC20-mediated polyubiquitination and proteasomal degradation of REV1. REV7 binds to an N-terminal region of REV1 that contains both the APC degron and an additional REV7-binding domain. Depletion of REV7 stabilizes REV1 by preventing polyubiquitination.","method":"Co-immunoprecipitation, ubiquitination assay, siRNA knockdown, overexpression of APC co-activators","journal":"Cell Cycle","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple protein interaction and functional assays, single lab","pmids":["23287467"],"is_preprint":false},{"year":2013,"finding":"NMR mapping shows that the Rev1 BRCT domain of S. cerevisiae directly interacts with PCNA in solution. The PCNA-binding interface of the Rev1-BRCT domain comprises conserved residues of the outer α1-helix surface and flanking loops. Rev1-BRCT binds the inter-domain region of PCNA that overlaps with the PIP-box binding site; Rev1-BRCT and Pol-eta PIP-box interactions with the same PCNA monomer are mutually exclusive.","method":"Solution NMR structure of Rev1-BRCT, TROSY NMR binding analysis with 87 kDa PCNA, competition with PIP-box peptide","journal":"Journal of Molecular Biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure with direct binding characterization and competition experiment, single lab","pmids":["23747975"],"is_preprint":false},{"year":2014,"finding":"REV1-deficient cells are compromised in replicating G-quadruplex (G4)-forming DNA, leading to stochastic loss of parental histone marks (H3K4me3, H3K9/14ac) and changes in gene expression. A single G4 motif on the leading strand template is responsible for this epigenetic instability at the BU-1 locus, with effects depending on the G4's distance from the TSS.","method":"Gene disruption in DT40 cells, ChIP for histone marks, gene expression analysis, G4 motif mutagenesis","journal":"EMBO Journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic disruption with mechanistic dissection of G4 position requirements, single lab","pmids":["25190518"],"is_preprint":false},{"year":2015,"finding":"Rev1-Pol-zeta complex recruitment to interstrand crosslink (ICL) sites requires the Fanconi anemia core complex but not FancI-FancD2. The extension step of ICL bypass involves a Rev1-Pol-zeta complex. Deep sequencing shows ICL repair introduces a short mutagenic tract with ~1% maximum mutation frequency.","method":"Site-specific ICL in Xenopus egg extracts, deep sequencing of repair products, immunodepletion experiments","journal":"EMBO Journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted cell-free system with site-specific lesion, genetic depletion, and deep sequencing of repair products","pmids":["26071591"],"is_preprint":false},{"year":2015,"finding":"Rev1 is targeted to laser-induced DNA damage in a manner dependent on its ubiquitin-binding motifs (UBMs), RAD18, and monoubiquitinated FANCD2 (FANCD2-mUb) which associates with REV1. Expression of FANCD2-Ub chimera in RAD18-depleted cells enhances REV1 assembly at damage sites. REV1 also protects nascent replication tracts from degradation by stabilizing RAD51 filaments.","method":"Laser microirradiation and immunofluorescence, co-immunoprecipitation, DNA fiber assay","journal":"Nucleic Acids Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiments with genetic dissection of requirements, RAD51 fiber protection assay, single lab","pmids":["26187992"],"is_preprint":false},{"year":2015,"finding":"In human and mouse cells, Rev1 is indispensable for TLS mediated by Pol-eta, Pol-iota, and Pol-kappa opposite UV lesions, but is not required for Pol-zeta-dependent TLS. Rev1 promotes predominantly error-free TLS opposite UV lesions in humans, acting as an indispensable scaffolding component for Y-family polymerases.","method":"siRNA/gene knockout in human and mouse fibroblasts, single lesion plasmid TLS assay","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — systematic depletion of multiple polymerases with defined lesion bypass assay, distinguishes human from yeast function","pmids":["26680302"],"is_preprint":false},{"year":2016,"finding":"PolD3, a subunit of the four-subunit Pol-zeta complex, contains an RIR motif whose interaction with Rev1-CT is among the tightest mediated by RIR motifs. NMR structure of Rev1-CT/PolD3-RIR complex reveals structural basis for high affinity. This suggests a mechanism for polymerase switching: PolD3-RIR binding to Rev1-CT displaces inserter polymerases and facilitates assembly of the full Pol-zeta extender complex.","method":"NMR structure determination of Rev1-CT/PolD3-RIR complex, binding affinity measurements","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure with quantitative binding affinity data, mechanistic polymerase switch model supported","pmids":["26982350"],"is_preprint":false},{"year":2016,"finding":"Budding yeast Rad5 physically interacts with Rev1 via an RFF motif in the Rad5 N-terminus that binds a hydrophobic pocket within the Rev1 CTD. Crystal structure of the Rad5-Rev1 interaction was determined. Rad5's TLS function (via Rev1 recruitment) and its error-free DDT function (via E3 ligase) are separable. Disrupting the Rev1-Rad5 interaction inactivates Rev1's non-catalytic TLS function.","method":"Domain mapping, crystal structure of Rad5-Rev1 interaction, genetic separation-of-function analysis","journal":"Nucleic Acids Research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure with functional genetic validation, single lab","pmids":["27001510"],"is_preprint":false},{"year":2016,"finding":"REV1 promotes PCNA monoubiquitylation after UV radiation by interacting with ubiquitylated RAD18, which facilitates release of non-ubiquitylated RAD18 from ubiquitylated RAD18 trapping and allows RAD18 chromatin recruitment. This stimulatory effect also occurs after hydroxyurea and mitomycin C treatment but not MMS.","method":"Co-immunoprecipitation, PCNA ubiquitylation assay, chromatin fractionation","journal":"Journal of Cell Science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP identifying novel interaction and biochemical stimulation assay, single lab","pmids":["26795561"],"is_preprint":false},{"year":2016,"finding":"The PIP motif of yeast Pol-eta mediates interactions with both PCNA and Rev1 CTD, binding in the hydrophobic pocket of the Rev1 C-terminal domain. RIR motifs of human Pol-kappa and PIP motifs of yeast Msh6 can also bind both PCNA and Rev1, demonstrating overlapping specificities of PIP and RIR motifs.","method":"Binding assays, fluorescence polarization, yeast two-hybrid, mutagenesis","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple binding assays with multiple proteins, single lab","pmids":["26903512"],"is_preprint":false},{"year":2018,"finding":"Rev7 dimerizes (homodimer) when tethered by the two Rev7-binding motifs (RBMs) in Rev3, using the conventional HORMA dimerization interface. The Rev7 dimer can bind only one copy of Rev1, revealing an unexpected 1:2:1 Rev1:Rev7:Rev3 architecture. Rev7 also heterodimerizes with Mad2 and p31comet. Mutation of the Rev7 dimer interface increases cellular sensitivity to DNA damage.","method":"In vitro structural analysis, biochemical interaction studies, functional assay in Rev7-/- cells","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — combination of structural and biochemical analysis with in vivo functional validation","pmids":["30111544"],"is_preprint":false},{"year":2015,"finding":"Starvation induces SUMO2/3 modification (SUMOylation) of REV1, which relieves REV1's inhibition of p53, enhancing p53-dependent proapoptotic gene expression and apoptosis in cancer cells. REV1 is a novel binding partner of tumor suppressor p53 and regulates its activity.","method":"Co-immunoprecipitation (REV1-p53 interaction), SUMOylation assay, gene expression analysis, apoptosis assay","journal":"Cancer Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — novel protein interaction identified by Co-IP with functional consequence for p53 activity, single lab","pmids":["25614517"],"is_preprint":false},{"year":2011,"finding":"Hsp90 binds REV1 in vivo and in vitro. Inhibition of Hsp90 reduces REV1 protein levels through proteasomal degradation, suppresses UV-induced mutagenesis, disrupts the interaction between REV1 and monoubiquitinated PCNA, and suppresses UV-induced REV1 focus formation. Hsp90 promotes correct folding of REV1 to enable its interaction with monoubiquitinated PCNA.","method":"Co-immunoprecipitation (in vivo and in vitro), Hsp90 inhibitor treatment, immunofluorescence for foci, mutagenesis assay","journal":"Molecular and Cellular Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with functional dissection using specific inhibitor, single lab","pmids":["21690293"],"is_preprint":false},{"year":2021,"finding":"REV1-Pol-zeta (inhibited by small molecule JH-RE-06) maintains viability of BRCA1/2-deficient cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps. Gap accumulation requires SMUG1 glycosylase and is exacerbated by RAD18 depletion or REV1-Pol-zeta inhibition. JH-RE-06 is preferentially toxic toward HR-deficient cancer cells and acts additively with crosslinking agents or PARP inhibitors.","method":"DNA fiber analysis, electron microscopy, small molecule inhibitor (JH-RE-06), siRNA knockdown, mouse xenograft models","journal":"Molecular Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (EM, DNA fiber, genetics, in vivo models) establishing pathway position","pmids":["34508659"],"is_preprint":false},{"year":2006,"finding":"Human REV1 has a higher affinity for single-stranded DNA (ssDNA) than for primer termini, targeting it to included primer termini. This property requires the N- and C-terminal domains (the catalytic core alone loses this function). This distinguishes REV1 from other DNA polymerases including Pol-alpha, Pol-beta, and Pol-eta.","method":"In vitro DNA binding assays with purified human REV1 and deletion mutants","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding assay with domain deletion analysis, single lab","pmids":["16803901"],"is_preprint":false}],"current_model":"REV1 is a specialized Y-family DNA polymerase that operates via a unique protein-template mechanism—evicting the templating base from the helix and pairing incoming dCTP with a conserved surrogate arginine (Arg324)—to insert dCMP opposite template G, abasic sites, and numerous N2-guanine adducts; beyond this catalytic role, REV1 serves as an essential scaffolding protein whose C-terminal domain (a four-helix bundle) simultaneously coordinates polymerase switching by binding Rev7 (and thus Pol-zeta) and the FF-containing RIR/PIP motifs of Y-family insertion polymerases (Pol-eta, -iota, -kappa), while its N-terminal BRCT domain mediates PCNA binding and early TLS, its UBMs recruit it to monoubiquitinated PCNA and FANCD2, and its cell-cycle-regulated expression (peaking in G2/M) and post-translational modifications (phosphorylation, SUMOylation, APC/REV7-dependent degradation, Hsp90-dependent folding) control the timing and magnitude of mutagenic translesion synthesis."},"narrative":{"mechanistic_narrative":"REV1 is a specialized Y-family DNA polymerase and central scaffolding protein of the translesion synthesis (TLS) machinery that enables cells to tolerate DNA damage at the cost of mutagenesis [PMID:8751446, PMID:12660171, PMID:26680302]. As an enzyme, REV1 is a template-independent deoxycytidyl (dCMP) transferase that inserts dCMP opposite template guanine, abasic sites, and a range of N2-guanine minor-groove adducts [PMID:8751446, PMID:10536157, PMID:18591245]. Crystal structures of yeast and human ternary complexes establish its unique protein-template mechanism: the templating base (or abasic lesion) is evicted from the helix and incoming dCTP is paired not with the template but with a conserved surrogate arginine (Arg324) [PMID:16195463, PMID:18275815, PMID:19464298]. This catalytic activity is biologically relevant chiefly for accurate C insertion opposite endogenous abasic sites and N2-dG adducts [PMID:20980236, PMID:22024240]. Beyond catalysis, REV1's principal in vivo role is as a non-catalytic scaffold: its C-terminal four-helix-bundle domain simultaneously binds Rev7 (recruiting Pol-zeta) and the FF-containing RIR/PIP motifs of the insertion polymerases Pol-eta, Pol-iota, and Pol-kappa, thereby coordinating the polymerase switch between insertion and Pol-zeta-mediated extension [PMID:14657033, PMID:19170759, PMID:22859295, PMID:22700975]. REV1 is recruited to damage sites through its BRCT domain, which binds PCNA and 5'-phosphorylated recessed primer-template junctions, and through C-terminal ubiquitin-binding motifs (UBMs) that engage monoubiquitinated PCNA and FANCD2 [PMID:16857592, PMID:16982685, PMID:20159559, PMID:26187992]. This recruitment couples REV1 to the Rad6/Rad18-PCNA-ubiquitination axis and to the Fanconi anemia pathway during interstrand crosslink repair [PMID:16344468, PMID:22266823, PMID:26071591]. REV1 expression and activity are tightly controlled across the cell cycle by peak G2/M abundance, MEC1/ATR-dependent phosphorylation, Hsp90-dependent folding, and APC/REV7-dependent degradation [PMID:16751278, PMID:17035102, PMID:23287467, PMID:21690293]. Functionally, REV1 is required for damage-induced point mutagenesis, immunoglobulin gene diversification and class switch recombination, replication through G-quadruplex structures, and the mutagenic filling of PRIMPOL-dependent ssDNA gaps that sustains viability of HR-deficient cancer cells [PMID:12660171, PMID:23140944, PMID:25190518, PMID:34508659].","teleology":[{"year":1996,"claim":"Established REV1's defining biochemical activity, answering what reaction the protein catalyzes: a template-dependent dCMP transferase that acts opposite abasic sites and guanine.","evidence":"In vitro dCMP transferase assay with purified yeast Rev1; conserved in purified human REV1","pmids":["8751446","10536157"],"confidence":"High","gaps":["Did not establish the structural basis for dCMP selectivity","In vivo relevance of catalysis versus scaffolding unresolved"]},{"year":2002,"claim":"Quantitative kinetics defined REV1 as a low-processivity, G-template-specific polymerase, clarifying that its insertion fidelity is biased toward C opposite G rather than broad lesion bypass.","evidence":"Steady-state kinetics of nucleotide incorporation by purified yeast Rev1 across multiple substrates","pmids":["11850424"],"confidence":"High","gaps":["Did not resolve whether catalytic insertion or structural roles dominate at abasic sites in vivo"]},{"year":2001,"claim":"Genetic and reconstitution analysis indicated that at abasic sites REV1's predominant contribution is structural rather than catalytic, reframing it as a pathway organizer alongside Pol-delta and Pol-zeta.","evidence":"Genetic epistasis plus in vitro reconstitution and kinetics in yeast","pmids":["11316789"],"confidence":"High","gaps":["Structural role mechanism not defined at molecular level","Did not identify the scaffolding interactions later mapped"]},{"year":2003,"claim":"Identified REV1's scaffolding function by showing its C-terminus binds Pol-eta, -iota, -kappa, and Rev7 (Pol-zeta) at a common ~100-residue region, with Rev7 competing for binding — establishing REV1 as a polymerase-bridging hub.","evidence":"Co-IP, GST pulldown, and competition assays with mouse Rev1 and partner polymerases; loss-of-function in DT40 cells","pmids":["14657033","12660171"],"confidence":"High","gaps":["Structural basis of simultaneous versus competitive binding not yet resolved","Recruitment to lesions not yet mechanistically defined"]},{"year":2005,"claim":"Defined the recruitment logic: REV1's BRCT domain and C-terminal UBMs bind PCNA and monoubiquitinated PCNA respectively, coupling REV1 to the Rad18/PCNA-ubiquitination damage signal and to replication foci.","evidence":"Domain mutagenesis, Co-IP, foci imaging in DT40/mouse cells; in vitro TLS activation by ubiquitinated PCNA","pmids":["15741181","16857592","16982685","16344468"],"confidence":"High","gaps":["Temporal coordination of BRCT versus UBM recruitment not resolved","Structural detail of UBM-ubiquitin contact pending"]},{"year":2005,"claim":"Crystal structures of yeast Rev1 ternary complexes solved the central mechanistic question of nucleotide selection, revealing a protein-template mechanism with base eviction and Arg324 as a surrogate templating residue.","evidence":"X-ray crystallography of Rev1-DNA-dCTP ternary complexes at template G and abasic sites; conserved in human REV1 structure","pmids":["16195463","18275815","21167175","19464298"],"confidence":"High","gaps":["Did not address how scaffolding CTD is positioned relative to catalytic core","Conformational dynamics during base eviction not captured"]},{"year":2007,"claim":"Pinpointed the UBM-ubiquitin interface by mutagenesis and NMR, showing UBM contacts are required for damage-induced mutagenesis and survival, linking ubiquitin recognition to function.","evidence":"Mutational analysis, in vitro binding to ubiquitinated PCNA, NMR of UBM-ubiquitin complex, in vivo mutagenesis in yeast","pmids":["17517887","20159559"],"confidence":"High","gaps":["How UBM engagement is regulated during the cell cycle not defined"]},{"year":2009,"claim":"Defined the FF-containing RIR motif as the shared docking signal in Pol-eta/-iota/-kappa for the REV1 CTD, explaining how REV1 selects insertion polymerases.","evidence":"Yeast two-hybrid, pulldown, sequence alignment, and complementation in Polk-null MEFs","pmids":["19170759"],"confidence":"High","gaps":["Did not establish how competing RIR/Rev7 interactions are temporally ordered"]},{"year":2012,"claim":"Structures of the REV1 CTD four-helix bundle in complex with Rev7/Rev3 and RIR peptides resolved how REV1 simultaneously engages extension (Pol-zeta) and insertion polymerases via two distinct surfaces, providing the molecular basis for polymerase switching.","evidence":"X-ray crystallography of quaternary and ternary complexes and NMR of mouse/human CTD with conformational dynamics analysis","pmids":["22859295","22859296","22700975","22691049","22303021"],"confidence":"High","gaps":["Order of polymerase exchange events not directly observed","Coupling of CTD switching to the catalytic core unresolved"]},{"year":2012,"claim":"Connected REV1 to the Fanconi anemia pathway and to antibody diversification, showing FAAP20 binds monoubiquitinated Rev1 and that Rev1 scaffolds Ung to switch regions during class switch recombination independent of catalysis.","evidence":"Co-IP, ChIP, domain analysis, foci imaging, and catalytic-mutant rescue in B cells","pmids":["22266823","23140944"],"confidence":"High","gaps":["Mechanistic link between FA recruitment and TLS polymerase loading incompletely defined"]},{"year":2016,"claim":"Refined the polymerase-switch model by showing PolD3-RIR binds the REV1 CTD with high affinity and that PIP and RIR motifs have overlapping specificities, suggesting how the full Pol-zeta extender is assembled after inserter displacement.","evidence":"NMR structures and binding-affinity measurements of Rev1-CT complexes with PolD3-RIR and PIP/RIR peptides","pmids":["26982350","26903512","27001510"],"confidence":"High","gaps":["Kinetics of switch in the context of an active replication fork not measured"]},{"year":2016,"claim":"Established that human REV1 is an indispensable scaffold for Y-family-mediated, predominantly error-free TLS opposite UV lesions, distinguishing its mammalian function from yeast and from Pol-zeta-dependent bypass.","evidence":"Systematic siRNA/knockout of multiple polymerases with single-lesion plasmid TLS assays in human and mouse cells","pmids":["26680302"],"confidence":"High","gaps":["Relative contribution of catalytic versus scaffolding REV1 to error-free bypass not fully partitioned"]},{"year":2014,"claim":"Revealed a replication-fidelity role beyond classical lesion bypass: REV1 is required to replicate G-quadruplex DNA, and its loss causes stochastic loss of parental histone marks and epigenetic instability.","evidence":"In vitro G4 unfolding/binding assays and DT40 knockout with ChIP for histone marks and G4-motif mutagenesis","pmids":["24366879","25190518"],"confidence":"Medium","gaps":["Whether G4 resolution at forks uses the same recruitment machinery as lesion TLS is unclear","Single-locus mechanism not generalized genome-wide"]},{"year":2021,"claim":"Positioned REV1-Pol-zeta in the mutagenic filling of PRIMPOL-dependent ssDNA gaps, defining a vulnerability of HR-deficient cancer cells and validating a small-molecule inhibitor (JH-RE-06).","evidence":"DNA fiber, electron microscopy, knockdown, inhibitor treatment, and xenograft models","pmids":["34508659"],"confidence":"High","gaps":["Substrate scope of gap-filling beyond BRCA-deficient context not defined","How gap-filling integrates with cell-cycle-regulated REV1 abundance unresolved"]},{"year":null,"claim":"How REV1's catalytic core, its scaffolding CTD, and its multiple regulatory inputs (phosphorylation, SUMOylation, Hsp90 folding, APC/REV7 degradation) are integrated into a single dynamic complex that orders insertion, switching, and extension at a fork remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structure of full-length REV1 with both catalytic and scaffolding modules engaged","Quantitative timing of polymerase exchange in vivo not measured","Regulatory crosstalk among PTMs not mechanistically connected"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[0,1,4,10,26,27,31,40]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,4,26]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[4,34,39,63]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[6,29,43,45,47]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[15,16,22,24]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[18,32]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[7,23,52,54]},{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[12,23,62]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[24,42,52,62]}],"complexes":["REV1-Pol-zeta (REV1-REV7-REV3) translesion polymerase complex","REV1-REV7 heterodimer"],"partners":["REV7","REV3","POLH","POLK","POLI","PCNA","FAAP20","FANCD2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UBZ9","full_name":"Translesion synthesis protein REV1","aliases":["Alpha integrin-binding protein 80","AIBP80","Molecular adapter protein REV1","Rev1-like terminal deoxycytidyl transferase","Reversionless protein 1 homolog","REV1 homolog","Template-dependent deoxycytidyl transferase REV1"],"length_aa":1251,"mass_kda":138.2,"function":"Bifunctional protein involved in the maintenance of genome stability through translesion DNA synthesis (TLS) and antibody diversification via somatic hypermutation (PubMed:16263170, PubMed:23143872). Functions as a molecular adapter protein at stalled DNA replication, coordinating polymerases recruitment, selection, and switching, in a manner independent of its deoxycytidyl transferase activity (PubMed:23143872). At the site of DNA lesion, recruits and mediates the switch between low-fidelity inserter DNA polymerases, such as POLK, that incorporate nucleotides opposite lesions and the extender DNA polymerase zeta complex which continues DNA synthesis from distorted primer termini (PubMed:23143872). In vitro, acts as a template-dependent deoxycytidyl transferase that preferentially incorporates deoxycytidine residues from dCTP to the 3'-end of a DNA primer opposite apurinic/apyrimidinic (AP) site, uracil, undamaged DNA templates (G > A > C > T) and a variety of damaged DNA templates (PubMed:10536157, PubMed:11278384, PubMed:38612916). Opposite template guanine, efficiently incorporates not only dCMP but also non-complementary dGMP and dTMP, with lower efficiency for dAMP, demonstrating low fidelity on undamaged DNA (PubMed:10536157, PubMed:11711549, PubMed:38612916). This catalytic activity has been implicated in somatic hypermutation, likely achieved by incorporation of deoxycytidine opposite abasic sites, generated at cytidines via activation-induced deoxycytidine deaminase (AID)-mediated deamination and uracil DNA glycosylase (UNG) activity, respectively (PubMed:16263170). In addition, exhibits a 5'-deoxyribose-5-phosphate lyase activity in vitro, though its necessity in vivo is not confirmed (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9UBZ9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/REV1","classification":"Not Classified","n_dependent_lines":56,"n_total_lines":1208,"dependency_fraction":0.046357615894039736},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/REV1","total_profiled":1310},"omim":[{"mim_id":"616086","title":"SprT-LIKE N-TERMINAL DOMAIN PROTEIN; SPRTN","url":"https://www.omim.org/entry/616086"},{"mim_id":"608952","title":"REPLICATION TIMING REGULATORY FACTOR 1; RIF1","url":"https://www.omim.org/entry/608952"},{"mim_id":"606134","title":"REV1 DNA-DIRECTED POLYMERASE; REV1","url":"https://www.omim.org/entry/606134"},{"mim_id":"605650","title":"POLYMERASE, DNA, KAPPA; POLK","url":"https://www.omim.org/entry/605650"},{"mim_id":"605230","title":"TUMOR PROTEIN p53-BINDING PROTEIN 1; TP53BP1","url":"https://www.omim.org/entry/605230"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoli","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/REV1"},"hgnc":{"alias_symbol":[],"prev_symbol":["REV1L"]},"alphafold":{"accession":"Q9UBZ9","domains":[{"cath_id":"3.40.50.10190","chopping":"24-130","consensus_level":"high","plddt":85.7058,"start":24,"end":130},{"cath_id":"3.30.1490.100","chopping":"711-828","consensus_level":"high","plddt":96.3147,"start":711,"end":828},{"cath_id":"1.20.58.1280","chopping":"1166-1245","consensus_level":"high","plddt":88.3026,"start":1166,"end":1245}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UBZ9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UBZ9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UBZ9-F1-predicted_aligned_error_v6.png","plddt_mean":66.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=REV1","jax_strain_url":"https://www.jax.org/strain/search?query=REV1"},"sequence":{"accession":"Q9UBZ9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UBZ9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UBZ9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UBZ9"}},"corpus_meta":[{"pmid":"8751446","id":"PMC_8751446","title":"Deoxycytidyl transferase activity of yeast REV1 protein.","date":"1996","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8751446","citation_count":504,"is_preprint":false},{"pmid":"14657033","id":"PMC_14657033","title":"Mouse Rev1 protein interacts with multiple DNA polymerases involved in translesion DNA synthesis.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/14657033","citation_count":303,"is_preprint":false},{"pmid":"11316789","id":"PMC_11316789","title":"Roles of yeast DNA polymerases delta and zeta and of Rev1 in the bypass of abasic sites.","date":"2001","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/11316789","citation_count":300,"is_preprint":false},{"pmid":"18498753","id":"PMC_18498753","title":"PCNA ubiquitination and REV1 define temporally distinct mechanisms for controlling translesion synthesis in the avian cell line DT40.","date":"2008","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/18498753","citation_count":216,"is_preprint":false},{"pmid":"16195463","id":"PMC_16195463","title":"Rev1 employs a novel mechanism of DNA synthesis using a protein template.","date":"2005","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/16195463","citation_count":208,"is_preprint":false},{"pmid":"16344468","id":"PMC_16344468","title":"Ubiquitinated proliferating cell nuclear antigen activates translesion DNA polymerases eta and REV1.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16344468","citation_count":202,"is_preprint":false},{"pmid":"16857592","id":"PMC_16857592","title":"REV1 protein interacts with PCNA: significance of the REV1 BRCT domain in vitro and in vivo.","date":"2006","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/16857592","citation_count":180,"is_preprint":false},{"pmid":"12509231","id":"PMC_12509231","title":"Cellular roles of DNA polymerase zeta and Rev1 protein.","date":"2002","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/12509231","citation_count":179,"is_preprint":false},{"pmid":"16982685","id":"PMC_16982685","title":"Ubiquitin-binding motifs in REV1 protein are required for its role in the tolerance of DNA damage.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16982685","citation_count":176,"is_preprint":false},{"pmid":"16476771","id":"PMC_16476771","title":"Strand-biased defect in C/G transversions in hypermutating immunoglobulin genes in Rev1-deficient mice.","date":"2006","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16476771","citation_count":171,"is_preprint":false},{"pmid":"10760286","id":"PMC_10760286","title":"The function of the human homolog of Saccharomyces cerevisiae REV1 is required for mutagenesis induced by UV light.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10760286","citation_count":160,"is_preprint":false},{"pmid":"10536157","id":"PMC_10536157","title":"The human REV1 gene codes for a DNA template-dependent dCMP transferase.","date":"1999","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/10536157","citation_count":158,"is_preprint":false},{"pmid":"15520252","id":"PMC_15520252","title":"The relative roles in vivo of Saccharomyces cerevisiae Pol eta, Pol zeta, Rev1 protein and Pol32 in the bypass and mutation induction of an abasic site, T-T (6-4) photoadduct and T-T cis-syn cyclobutane dimer.","date":"2004","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15520252","citation_count":156,"is_preprint":false},{"pmid":"12660171","id":"PMC_12660171","title":"Rev1 is essential for DNA damage tolerance and non-templated immunoglobulin gene mutation in a vertebrate cell line.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12660171","citation_count":155,"is_preprint":false},{"pmid":"34508659","id":"PMC_34508659","title":"REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps.","date":"2021","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/34508659","citation_count":153,"is_preprint":false},{"pmid":"16751278","id":"PMC_16751278","title":"The critical mutagenic translesion DNA polymerase Rev1 is highly expressed during G(2)/M phase rather than S phase.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16751278","citation_count":149,"is_preprint":false},{"pmid":"15609317","id":"PMC_15609317","title":"Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk.","date":"2005","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15609317","citation_count":137,"is_preprint":false},{"pmid":"11850424","id":"PMC_11850424","title":"Yeast Rev1 protein is a G template-specific DNA polymerase.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11850424","citation_count":132,"is_preprint":false},{"pmid":"15741181","id":"PMC_15741181","title":"Vertebrate DNA damage tolerance requires the C-terminus but not BRCT or transferase domains of REV1.","date":"2005","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/15741181","citation_count":130,"is_preprint":false},{"pmid":"2492497","id":"PMC_2492497","title":"The REV1 gene of Saccharomyces cerevisiae: isolation, sequence, and functional analysis.","date":"1989","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/2492497","citation_count":127,"is_preprint":false},{"pmid":"11917024","id":"PMC_11917024","title":"Response of human REV1 to different DNA damage: preferential dCMP insertion opposite the lesion.","date":"2002","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/11917024","citation_count":121,"is_preprint":false},{"pmid":"22266823","id":"PMC_22266823","title":"Regulation of Rev1 by the Fanconi anemia core complex.","date":"2012","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22266823","citation_count":116,"is_preprint":false},{"pmid":"26071591","id":"PMC_26071591","title":"Regulation of the Rev1-pol ζ complex during bypass of a DNA interstrand cross-link.","date":"2015","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/26071591","citation_count":112,"is_preprint":false},{"pmid":"20028736","id":"PMC_20028736","title":"Differential roles for DNA polymerases eta, zeta, and REV1 in lesion bypass of intrastrand versus interstrand DNA cross-links.","date":"2009","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20028736","citation_count":111,"is_preprint":false},{"pmid":"20888339","id":"PMC_20888339","title":"Translesion synthesis across abasic lesions by human B-family and Y-family DNA polymerases α, δ, η, ι, κ, and REV1.","date":"2010","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20888339","citation_count":111,"is_preprint":false},{"pmid":"20164194","id":"PMC_20164194","title":"Crystal structure of human REV7 in complex with a human REV3 fragment and structural implication of the interaction between DNA polymerase zeta and REV1.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20164194","citation_count":107,"is_preprint":false},{"pmid":"17030609","id":"PMC_17030609","title":"Complex formation with Rev1 enhances the proficiency of Saccharomyces cerevisiae DNA polymerase zeta for mismatch extension and for extension opposite from DNA lesions.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17030609","citation_count":107,"is_preprint":false},{"pmid":"25190518","id":"PMC_25190518","title":"Determinants of G quadruplex-induced epigenetic instability in REV1-deficient cells.","date":"2014","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/25190518","citation_count":107,"is_preprint":false},{"pmid":"22859295","id":"PMC_22859295","title":"Structural basis of Rev1-mediated assembly of a quaternary vertebrate translesion polymerase complex consisting of Rev1, heterodimeric polymerase (Pol) ζ, and Pol κ.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22859295","citation_count":106,"is_preprint":false},{"pmid":"21926160","id":"PMC_21926160","title":"REV1 and polymerase ζ facilitate homologous recombination repair.","date":"2011","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/21926160","citation_count":105,"is_preprint":false},{"pmid":"22761336","id":"PMC_22761336","title":"MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition.","date":"2012","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/22761336","citation_count":103,"is_preprint":false},{"pmid":"32577513","id":"PMC_32577513","title":"Inhibition of the translesion synthesis polymerase REV1 exploits replication gaps as a cancer vulnerability.","date":"2020","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/32577513","citation_count":100,"is_preprint":false},{"pmid":"17517887","id":"PMC_17517887","title":"A ubiquitin-binding motif in the translesion DNA polymerase Rev1 mediates its essential functional interaction with ubiquitinated proliferating cell nuclear antigen in response to DNA damage.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17517887","citation_count":92,"is_preprint":false},{"pmid":"22859296","id":"PMC_22859296","title":"Structural basis of recruitment of DNA polymerase ζ by interaction between REV1 and REV7 proteins.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22859296","citation_count":89,"is_preprint":false},{"pmid":"15282292","id":"PMC_15282292","title":"Efficient and error-free replication past a minor-groove N2-guanine adduct by the sequential action of yeast Rev1 and DNA polymerase zeta.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15282292","citation_count":87,"is_preprint":false},{"pmid":"24049079","id":"PMC_24049079","title":"DNA polymerases ζ and Rev1 mediate error-prone bypass of non-B DNA structures.","date":"2013","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/24049079","citation_count":86,"is_preprint":false},{"pmid":"19170759","id":"PMC_19170759","title":"Identification of a novel REV1-interacting motif necessary for DNA polymerase kappa function.","date":"2009","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/19170759","citation_count":86,"is_preprint":false},{"pmid":"19332561","id":"PMC_19332561","title":"Separate domains of Rev1 mediate two modes of DNA damage bypass in mammalian cells.","date":"2009","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19332561","citation_count":83,"is_preprint":false},{"pmid":"16571727","id":"PMC_16571727","title":"REV3 and REV1 play major roles in recombination-independent repair of DNA interstrand cross-links mediated by monoubiquitinated proliferating cell nuclear antigen (PCNA).","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16571727","citation_count":79,"is_preprint":false},{"pmid":"18448394","id":"PMC_18448394","title":"The Fanconi anemia core complex is required for efficient point mutagenesis and Rev1 foci assembly.","date":"2008","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/18448394","citation_count":76,"is_preprint":false},{"pmid":"16227619","id":"PMC_16227619","title":"Complex formation of yeast Rev1 and Rev7 proteins: a novel role for the polymerase-associated domain.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16227619","citation_count":75,"is_preprint":false},{"pmid":"22700975","id":"PMC_22700975","title":"Multifaceted recognition of vertebrate Rev1 by translesion polymerases ζ and κ.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22700975","citation_count":74,"is_preprint":false},{"pmid":"15653636","id":"PMC_15653636","title":"The BRCT domain of mammalian Rev1 is involved in regulating DNA translesion synthesis.","date":"2005","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/15653636","citation_count":71,"is_preprint":false},{"pmid":"22691049","id":"PMC_22691049","title":"NMR structure and dynamics of the C-terminal domain from human Rev1 and its complex with Rev1 interacting region of DNA polymerase η.","date":"2012","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22691049","citation_count":70,"is_preprint":false},{"pmid":"24366879","id":"PMC_24366879","title":"Human Rev1 polymerase disrupts G-quadruplex DNA.","date":"2013","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/24366879","citation_count":67,"is_preprint":false},{"pmid":"19464298","id":"PMC_19464298","title":"Structure of the human Rev1-DNA-dNTP ternary complex.","date":"2009","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19464298","citation_count":67,"is_preprint":false},{"pmid":"16546083","id":"PMC_16546083","title":"ATR homolog Mec1 controls association of DNA polymerase zeta-Rev1 complex with regions near a double-strand break.","date":"2006","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/16546083","citation_count":67,"is_preprint":false},{"pmid":"27001510","id":"PMC_27001510","title":"Involvement of budding yeast Rad5 in translesion DNA synthesis through physical interaction with Rev1.","date":"2016","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/27001510","citation_count":66,"is_preprint":false},{"pmid":"20159559","id":"PMC_20159559","title":"Unconventional ubiquitin recognition by the ubiquitin-binding motif within the Y family DNA polymerases iota and Rev1.","date":"2010","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/20159559","citation_count":65,"is_preprint":false},{"pmid":"12529368","id":"PMC_12529368","title":"Structure and enzymatic properties of a stable complex of the human REV1 and REV7 proteins.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12529368","citation_count":60,"is_preprint":false},{"pmid":"19687253","id":"PMC_19687253","title":"Oncogene homologue Sch9 promotes age-dependent mutations by a superoxide and Rev1/Polzeta-dependent mechanism.","date":"2009","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19687253","citation_count":57,"is_preprint":false},{"pmid":"18591245","id":"PMC_18591245","title":"Kinetic analysis of translesion synthesis opposite bulky N2- and O6-alkylguanine DNA adducts by human DNA polymerase REV1.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18591245","citation_count":56,"is_preprint":false},{"pmid":"26982350","id":"PMC_26982350","title":"Interaction between the Rev1 C-Terminal Domain and the PolD3 Subunit of Polζ Suggests a Mechanism of Polymerase Exchange upon Rev1/Polζ-Dependent Translesion Synthesis.","date":"2016","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26982350","citation_count":55,"is_preprint":false},{"pmid":"18275815","id":"PMC_18275815","title":"Protein-template-directed synthesis across an acrolein-derived DNA adduct by yeast Rev1 DNA polymerase.","date":"2008","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/18275815","citation_count":53,"is_preprint":false},{"pmid":"11278384","id":"PMC_11278384","title":"Deoxycytidyl transferase activity of the human REV1 protein is closely associated with the conserved polymerase domain.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278384","citation_count":53,"is_preprint":false},{"pmid":"17035102","id":"PMC_17035102","title":"Yeast Rev1 is cell cycle regulated, phosphorylated in response to DNA damage and its binding to chromosomes is dependent upon MEC1.","date":"2006","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/17035102","citation_count":52,"is_preprint":false},{"pmid":"19487673","id":"PMC_19487673","title":"Yeast Rev1 protein promotes complex formation of DNA polymerase zeta with Pol32 subunit of DNA polymerase delta.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19487673","citation_count":52,"is_preprint":false},{"pmid":"30111544","id":"PMC_30111544","title":"Rev7 dimerization is important for assembly and function of the Rev1/Polζ translesion synthesis complex.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30111544","citation_count":51,"is_preprint":false},{"pmid":"16923957","id":"PMC_16923957","title":"Novel role for the C terminus of Saccharomyces cerevisiae Rev1 in mediating protein-protein interactions.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16923957","citation_count":49,"is_preprint":false},{"pmid":"16495473","id":"PMC_16495473","title":"Human REV1 modulates the cytotoxicity and mutagenicity of cisplatin in human ovarian carcinoma cells.","date":"2006","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16495473","citation_count":48,"is_preprint":false},{"pmid":"19157994","id":"PMC_19157994","title":"Interaction with DNA polymerase eta is required for nuclear accumulation of REV1 and suppression of spontaneous mutations in human cells.","date":"2009","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/19157994","citation_count":48,"is_preprint":false},{"pmid":"28541665","id":"PMC_28541665","title":"Identification of Small Molecule Translesion Synthesis Inhibitors That Target the Rev1-CT/RIR Protein-Protein Interaction.","date":"2017","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/28541665","citation_count":47,"is_preprint":false},{"pmid":"16824193","id":"PMC_16824193","title":"A human DNA polymerase eta complex containing Rad18, Rad6 and Rev1; proteomic analysis and targeting of the complex to the chromatin-bound fraction of cells undergoing replication fork arrest.","date":"2006","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/16824193","citation_count":47,"is_preprint":false},{"pmid":"20980236","id":"PMC_20980236","title":"The DNA polymerase activity of Saccharomyces cerevisiae Rev1 is biologically significant.","date":"2010","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20980236","citation_count":45,"is_preprint":false},{"pmid":"23747975","id":"PMC_23747975","title":"NMR mapping of PCNA interaction with translesion synthesis DNA polymerase Rev1 mediated by Rev1-BRCT domain.","date":"2013","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23747975","citation_count":45,"is_preprint":false},{"pmid":"17875922","id":"PMC_17875922","title":"Complex formation of yeast Rev1 with DNA polymerase eta.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17875922","citation_count":43,"is_preprint":false},{"pmid":"23065650","id":"PMC_23065650","title":"REV1 and DNA polymerase zeta in DNA interstrand crosslink repair.","date":"2012","source":"Environmental and molecular mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/23065650","citation_count":42,"is_preprint":false},{"pmid":"26187992","id":"PMC_26187992","title":"FANCD2 and REV1 cooperate in the protection of nascent DNA strands in response to replication stress.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/26187992","citation_count":42,"is_preprint":false},{"pmid":"33168727","id":"PMC_33168727","title":"REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarks.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33168727","citation_count":42,"is_preprint":false},{"pmid":"18562671","id":"PMC_18562671","title":"Role of Dot1 in the response to alkylating DNA damage in Saccharomyces cerevisiae: regulation of DNA damage tolerance by the error-prone polymerases Polzeta/Rev1.","date":"2008","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18562671","citation_count":42,"is_preprint":false},{"pmid":"26903512","id":"PMC_26903512","title":"The Proliferating Cell Nuclear Antigen (PCNA)-interacting Protein (PIP) Motif of DNA Polymerase η Mediates Its Interaction with the C-terminal Domain of Rev1.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26903512","citation_count":42,"is_preprint":false},{"pmid":"22024240","id":"PMC_22024240","title":"The dCMP transferase activity of yeast Rev1 is biologically relevant during the bypass of endogenously generated AP sites.","date":"2011","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/22024240","citation_count":42,"is_preprint":false},{"pmid":"22303021","id":"PMC_22303021","title":"The vital role of polymerase ζ and REV1 in mutagenic, but not correct, DNA synthesis across benzo[a]pyrene-dG and recruitment of polymerase ζ by REV1 to replication-stalled site.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22303021","citation_count":41,"is_preprint":false},{"pmid":"15896814","id":"PMC_15896814","title":"Roles of the polymerase and BRCT domains of Rev1 protein in translesion DNA synthesis in yeast in vivo.","date":"2005","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/15896814","citation_count":41,"is_preprint":false},{"pmid":"23140944","id":"PMC_23140944","title":"Rev1 recruits ung to switch regions and enhances du glycosylation for immunoglobulin class switch DNA recombination.","date":"2012","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/23140944","citation_count":39,"is_preprint":false},{"pmid":"19176310","id":"PMC_19176310","title":"REV1 is implicated in the development of carcinogen-induced lung cancer.","date":"2009","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/19176310","citation_count":39,"is_preprint":false},{"pmid":"18603483","id":"PMC_18603483","title":"Novel conserved motifs in Rev1 C-terminus are required for mutagenic DNA damage tolerance.","date":"2008","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/18603483","citation_count":38,"is_preprint":false},{"pmid":"19587019","id":"PMC_19587019","title":"A critical role for REV1 in regulating the induction of C:G transitions and A:T mutations during Ig gene hypermutation.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19587019","citation_count":38,"is_preprint":false},{"pmid":"11356151","id":"PMC_11356151","title":"Eukaryotic mutagenesis and translesion replication dependent on DNA polymerase zeta and Rev1 protein.","date":"2001","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/11356151","citation_count":37,"is_preprint":false},{"pmid":"21799021","id":"PMC_21799021","title":"The non-canonical protein binding site at the monomer-monomer interface of yeast proliferating cell nuclear antigen (PCNA) regulates the Rev1-PCNA interaction and Polζ/Rev1-dependent translesion DNA synthesis.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21799021","citation_count":37,"is_preprint":false},{"pmid":"21752727","id":"PMC_21752727","title":"The Rev1 translesion synthesis polymerase has multiple distinct DNA binding modes.","date":"2011","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/21752727","citation_count":37,"is_preprint":false},{"pmid":"18242152","id":"PMC_18242152","title":"Comparative analysis of in vivo interactions between Rev1 protein and other Y-family DNA polymerases in animals and yeasts.","date":"2008","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/18242152","citation_count":37,"is_preprint":false},{"pmid":"25614517","id":"PMC_25614517","title":"Starvation promotes REV1 SUMOylation and p53-dependent sensitization of melanoma and breast cancer cells.","date":"2015","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/25614517","citation_count":34,"is_preprint":false},{"pmid":"26680302","id":"PMC_26680302","title":"Rev1 promotes replication through UV lesions in conjunction with DNA polymerases η, ι, and κ but not DNA polymerase ζ.","date":"2015","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/26680302","citation_count":34,"is_preprint":false},{"pmid":"12930947","id":"PMC_12930947","title":"Ribozyme-mediated REV1 inhibition reduces the frequency of UV-induced mutations in the human HPRT gene.","date":"2003","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/12930947","citation_count":33,"is_preprint":false},{"pmid":"16415180","id":"PMC_16415180","title":"Poleta, Polzeta and Rev1 together are required for G to T transversion mutations induced by the (+)- and (-)-trans-anti-BPDE-N2-dG DNA adducts in yeast cells.","date":"2006","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/16415180","citation_count":33,"is_preprint":false},{"pmid":"23142547","id":"PMC_23142547","title":"A non-catalytic function of Rev1 in translesion DNA synthesis and mutagenesis is mediated by its stable interaction with Rad5.","date":"2012","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/23142547","citation_count":32,"is_preprint":false},{"pmid":"31627876","id":"PMC_31627876","title":"The Rev1-Polζ translesion synthesis mutasome: Structure, interactions and inhibition.","date":"2019","source":"The Enzymes","url":"https://pubmed.ncbi.nlm.nih.gov/31627876","citation_count":31,"is_preprint":false},{"pmid":"21167175","id":"PMC_21167175","title":"DNA synthesis across an abasic lesion by yeast REV1 DNA polymerase.","date":"2010","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21167175","citation_count":31,"is_preprint":false},{"pmid":"12044876","id":"PMC_12044876","title":"Biochemical properties of the human REV1 protein.","date":"2002","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/12044876","citation_count":30,"is_preprint":false},{"pmid":"23287467","id":"PMC_23287467","title":"REV7 is required for anaphase-promoting complex-dependent ubiquitination and degradation of translesion DNA polymerase REV1.","date":"2012","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/23287467","citation_count":28,"is_preprint":false},{"pmid":"16803901","id":"PMC_16803901","title":"Role of single-stranded DNA in targeting REV1 to primer termini.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16803901","citation_count":28,"is_preprint":false},{"pmid":"15523096","id":"PMC_15523096","title":"REV1 accumulates in DNA damage-induced nuclear foci in human cells and is implicated in mutagenesis by benzo[a]pyrenediolepoxide.","date":"2004","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/15523096","citation_count":27,"is_preprint":false},{"pmid":"15175013","id":"PMC_15175013","title":"Purification of Drosophila DNA polymerase zeta by REV1 protein-affinity chromatography.","date":"2004","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15175013","citation_count":27,"is_preprint":false},{"pmid":"23857323","id":"PMC_23857323","title":"Rev1 is essential in generating G to C transversions downstream of the Ung2 pathway but not the Msh2+Ung2 hybrid pathway.","date":"2013","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23857323","citation_count":27,"is_preprint":false},{"pmid":"25080294","id":"PMC_25080294","title":"Mutational analysis of the C8-guanine adduct of the environmental carcinogen 3-nitrobenzanthrone in human cells: critical roles of DNA polymerases η and κ and Rev1 in error-prone translesion synthesis.","date":"2014","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25080294","citation_count":27,"is_preprint":false},{"pmid":"26795561","id":"PMC_26795561","title":"REV1 promotes PCNA monoubiquitylation through interacting with ubiquitylated RAD18.","date":"2016","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/26795561","citation_count":26,"is_preprint":false},{"pmid":"23761444","id":"PMC_23761444","title":"DNA-damage tolerance mediated by PCNA*Ub fusions in human cells is dependent on Rev1 but not Polη.","date":"2013","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/23761444","citation_count":26,"is_preprint":false},{"pmid":"21690293","id":"PMC_21690293","title":"Molecular chaperone Hsp90 regulates REV1-mediated mutagenesis.","date":"2011","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21690293","citation_count":24,"is_preprint":false},{"pmid":"19901007","id":"PMC_19901007","title":"Roles of Rev1, Pol zeta, Pol32 and Pol eta in the bypass of chromosomal abasic sites in Saccharomyces cerevisiae.","date":"2009","source":"Mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/19901007","citation_count":24,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45481,"output_tokens":14455,"usd":0.176634,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":27221,"output_tokens":5018,"usd":0.130777,"stage2_stop_reason":"end_turn"},"total_usd":0.307411,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"Yeast Rev1 protein has a deoxycytidyl transferase (dCMP transferase) activity, transferring a dCMP residue from dCTP to the 3' end of a DNA primer in a template-dependent reaction. Efficient transfer occurs opposite a template abasic site, and approximately 20% transfer occurs opposite template guanine. The inserted cytosine opposite an abasic site produces a terminus efficiently extended by Pol-zeta but not Pol-alpha.\",\n      \"method\": \"In vitro biochemical assay (dCMP transferase activity assay with purified protein)\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro enzymatic assay with purified protein, foundational paper replicated by multiple subsequent studies\",\n      \"pmids\": [\"8751446\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Human REV1 protein is a dCMP transferase that specifically inserts a dCMP residue opposite a template G, and efficiently inserts dCMP opposite template AP (apurinic/apyrimidinic) sites and uracil residues.\",\n      \"method\": \"In vitro biochemical assay with purified recombinant human REV1 protein\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro enzymatic characterization of purified human protein, replicated by multiple subsequent studies\",\n      \"pmids\": [\"10536157\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Yeast Rev1 is a G template-specific DNA polymerase: it specifically inserts a C residue opposite template G, and is approximately 25-, 40-, and 400-fold less efficient at inserting C opposite an abasic site, O6-methylguanine, and 8-oxoguanine, respectively. Rev1 has low processivity (~1.6 nucleotides per binding event).\",\n      \"method\": \"Steady-state kinetic analysis of nucleotide incorporation by purified yeast Rev1\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — rigorous steady-state kinetics with purified protein, multiple substrates tested\",\n      \"pmids\": [\"11850424\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"In AP site bypass, Rev1's predominant role is likely structural rather than catalytic insertion; the combined action of Pol-delta (inserting A opposite AP site) and Pol-zeta (extending) constitutes the major bypass pathway, with Rev1 and Pol-eta contributing to insertion of other nucleotides at lower frequency.\",\n      \"method\": \"Genetic epistasis analysis combined with in vitro reconstitution and steady-state kinetics\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — combined in vitro reconstitution, kinetics, and genetic analysis in yeast\",\n      \"pmids\": [\"11316789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The deoxycytidyl transferase activity of human REV1 is associated with its conserved polymerase domain; deletion and point mutation analysis demonstrated that the domain required for dCMP transferase and DNA binding activities resides within the conserved Y-family polymerase domain.\",\n      \"method\": \"Deletion and point mutation analysis of human REV1S protein, in vitro transferase assay\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis combined with in vitro enzymatic assay, single lab\",\n      \"pmids\": [\"11278384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Human REV1 is required for UV-induced mutagenesis; cells with reduced hREV1 mRNA via antisense expression show significantly lower frequencies of UV-induced 6-thioguanine-resistant mutants without affecting cytotoxic sensitivity.\",\n      \"method\": \"Antisense RNA knockdown in human cells, clonogenic survival and mutation frequency assays\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional loss-of-function with defined mutational phenotype readout, single lab\",\n      \"pmids\": [\"10760286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Mouse Rev1 physically associates with Pol-kappa, Pol-iota, Pol-eta, and Rev7 (subunit of Pol-zeta), and each of these proteins binds to the same ~100 amino acid C-terminal region of Rev1. Rev7 competes directly with Pol-kappa for binding to the Rev1 C-terminus. The DNA polymerase activity of Rev1 and Pol-kappa is unaffected when they form a complex.\",\n      \"method\": \"Co-immunoprecipitation, GST pulldown, in vitro primer extension assay\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal pulldowns identifying specific binding domain, competition assay, multiple interacting partners confirmed, replicated by subsequent structural studies\",\n      \"pmids\": [\"14657033\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Rev1-deficient DT40 cells grow slowly, are sensitive to a wide range of DNA-damaging agents, and show markedly reduced non-templated immunoglobulin gene mutation (translesion bypass). UV exposure causes chromosome breakage in Rev1-deficient cells. Homologous recombination (sister chromatid exchange and gene conversion) is unaffected.\",\n      \"method\": \"Gene disruption in DT40 cells, clonogenic survival, SCE assay, Ig gene mutation analysis, chromosome analysis\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean gene knockout with multiple orthogonal phenotypic readouts\",\n      \"pmids\": [\"12660171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Human REV1 and REV7 proteins form a stable heterodimer in solution. REV7 does not influence the stability, substrate specificity, or kinetic parameters of the transferase reactions of REV1 in contrast to the stimulatory effect of yeast Rev7 on Rev3.\",\n      \"method\": \"Purification of REV1-REV7 complex, biochemical analysis of transferase kinetics\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — purified complex with biochemical characterization, single lab\",\n      \"pmids\": [\"12529368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Rev1 efficiently incorporates C opposite the N2-propano-2'-deoxyguanosine (gamma-HOPdG) minor-groove adduct, from which Pol-zeta subsequently extends, completing error-free bypass. This supports a role for Rev1's DNA synthetic activity in bypassing N2-guanine minor-groove adducts by not contacting the DNA minor groove.\",\n      \"method\": \"In vitro primer extension assay with purified yeast Rev1 and Pol-zeta on adduct-containing templates\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted two-polymerase bypass assay with specific adduct, single lab\",\n      \"pmids\": [\"15282292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Crystal structure of yeast Rev1 bound to template G and incoming dCTP reveals that the polymerase dictates nucleotide identity via a protein-template mechanism: template G is evicted from the DNA helix and makes hydrogen bonds with a segment of Rev1, while incoming dCTP pairs with an arginine residue (Arg324) rather than the templating base.\",\n      \"method\": \"X-ray crystallography (crystal structure of ternary complex)\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with mechanistic validation, foundational structural paper widely cited\",\n      \"pmids\": [\"16195463\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Vertebrate DNA damage tolerance requires the C-terminus of REV1, which mediates interactions with PCNA, but does not require the BRCT domain or the catalytic transferase activity. A region adjacent to the polymerase-interacting domain mediates interaction with PCNA.\",\n      \"method\": \"Domain deletion/mutation analysis in avian DT40 cells, survival assays, co-immunoprecipitation\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple domain mutants tested in functional cellular assays with protein interaction data\",\n      \"pmids\": [\"15741181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Ubiquitinated PCNA (monoubiquitinated at Lys-164 by Rad6/Rad18) specifically activates Rev1 (and Pol-eta) for translesion synthesis in vitro, while DNA polymerase activity of Pol-zeta remains unaffected by PCNA ubiquitination.\",\n      \"method\": \"Robust in vitro ubiquitination system for yeast PCNA, in vitro TLS assay with ubiquitinated PCNA\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted in vitro system with purified components, direct activity measurement\",\n      \"pmids\": [\"16344468\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The yeast Rev1 PAD (polymerase-associated domain) mediates binding to Rev7 (accessory subunit of Pol-zeta), forming a stable Rev1-Rev7 complex that co-purifies. This reveals a novel role for the PAD in protein-protein interactions.\",\n      \"method\": \"Co-purification, co-immunoprecipitation from yeast\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-purification and co-IP demonstrating stable complex, single lab\",\n      \"pmids\": [\"16227619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Rev1 physically associates with Pol-zeta through its C-terminus binding to the Rev3 polymerase domain. A rev1 mutant lacking the C-terminal 72 residues (inactivating Rev3 interaction) shows the same UV sensitivity and loss of UV-induced mutagenesis as rev1Δ. Rev1 binding to Pol-zeta enhances Pol-zeta's proficiency for extending mismatched primer termini and primers opposite DNA lesions.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation from yeast, in vitro primer extension assay, UV survival and mutagenesis assays\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (Y2H, Co-IP, in vitro biochemistry, genetics), single lab but comprehensive\",\n      \"pmids\": [\"17030609\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Mouse REV1 binds directly to PCNA, and monoubiquitylation of PCNA enhances this interaction. The BRCT domain of REV1 is required for this interaction and for targeting REV1 to replication foci in unirradiated cells. Deletion or mutational inactivation of the BRCT domain abolishes REV1 targeting to replication foci in unirradiated cells (but not UV-irradiated cells) and is required for cell survival and DNA damage-induced mutagenesis in vivo.\",\n      \"method\": \"Co-immunoprecipitation, live-cell imaging of replication foci, genetic complementation in DT40 cells and yeast\",\n      \"journal\": \"Molecular Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods across multiple cell systems, direct protein interaction and localization with functional readout\",\n      \"pmids\": [\"16857592\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Mouse REV1 physically interacts with ubiquitin via ubiquitin-binding motifs (UBMs) located at the C-terminus of REV1. These UBMs mediate enhanced association between monoubiquitylated PCNA and REV1 and are required for UV-induced REV1 localization to replication foci, DNA damage tolerance, and damage-induced mutagenesis in vivo.\",\n      \"method\": \"Yeast two-hybrid, GST pulldown assay, cellular localization (foci assay), survival and mutagenesis assays\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple methods (Y2H, pulldown, cellular localization, functional assays), domain mapping with mutagenesis\",\n      \"pmids\": [\"16982685\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"S. cerevisiae Rev1 protein levels are subject to cell cycle control, being approximately 50-fold higher in G2/M than in G1/S phase. This cell cycle regulation is physiologically relevant: a rev1Δ strain shows differential survival after UV irradiation depending on the cell cycle stage at which UV is applied.\",\n      \"method\": \"Protein level measurement by western blot across cell cycle stages, UV survival assays at defined cell cycle stages\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct protein quantification across cell cycle with functional UV survival validation\",\n      \"pmids\": [\"16751278\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Yeast Rev1 is a phosphoprotein whose phosphorylation level is cell cycle regulated (unphosphorylated in G1, phosphorylated in S phase, hyper-phosphorylated in mitosis) and is further hyper-phosphorylated in response to DNA damage. Rev1 binds to chromosomes throughout the cell cycle in a MEC1-dependent manner, and phosphorylation does not modulate chromosome binding.\",\n      \"method\": \"Western blot (phosphoprotein analysis), chromosome spreading technique, genetic analysis with mec1 mutant\",\n      \"journal\": \"DNA Repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct phosphorylation analysis with chromosome binding experiment, but functional consequence of phosphorylation not resolved\",\n      \"pmids\": [\"17035102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Rev1 is required for efficient UV-induced mutagenesis in human cells; ribozyme-mediated reduction of REV1 mRNA (up to 90%) reduces UV-induced HPRT mutant frequency by up to 75% without affecting cytotoxic UV sensitivity.\",\n      \"method\": \"Ribozyme knockdown of REV1 mRNA in human cells, clonogenic survival, mutation frequency at HPRT locus\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional knockdown with specific mutational readout, single lab\",\n      \"pmids\": [\"12930947\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The yeast Rev1 C-terminus mediates interactions with Rev7 via both the PAD region and the extreme C-terminus and BRCT region. Elevated levels of the Rev1 C-terminus confer a dominant-negative effect on viability and induced mutagenesis after DNA damage, dependent on REV7.\",\n      \"method\": \"Co-immunoprecipitation from yeast crude extracts, dominant-negative overexpression assay, genetic analysis\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus dominant-negative genetics, single lab\",\n      \"pmids\": [\"16923957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"A ubiquitin-binding motif in the C-terminus of yeast Rev1 (residues L821, P822, I825) mediates functional interaction with the ubiquitin moiety of monoubiquitinated PCNA. Point mutations L821A,P822A,I825A abolish this interaction in vitro and strongly attenuate damage-induced mutagenesis in vivo.\",\n      \"method\": \"Mutational analysis of Rev1, in vitro binding assay with ubiquitinated PCNA, in vivo mutagenesis assay\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — active-site-equivalent mutagenesis combined with in vitro binding and in vivo functional validation, single lab\",\n      \"pmids\": [\"17517887\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Human REV1 accumulates at UV-irradiated areas of nuclei in cells expressing Pol-eta but not in Pol-eta-deficient XP-V cells. The Pol-eta–REV1 interaction (via FF residues in Pol-eta) is required for REV1 nuclear accumulation at UV damage sites and for suppression of spontaneous mutations, but not for accurate TLS of UV lesions.\",\n      \"method\": \"Immunofluorescence, complementation of XP-V cells with Pol-eta mutants, mutation frequency assay\",\n      \"journal\": \"DNA Repair\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiment with functional consequence, specific mutant rescue experiments\",\n      \"pmids\": [\"19157994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TLS at stalled replication forks in DT40 cells requires both the translesion polymerase-interaction domain and ubiquitin-binding domain in the REV1 C-terminus. PCNA ubiquitination is not required for maintaining normal fork progression on damaged DNA but is essential for filling postreplicative gaps. Thus, PCNA ubiquitination and REV1 play distinct, temporally separated roles in DNA damage bypass.\",\n      \"method\": \"Gene disruption and domain deletion/mutation analysis in DT40 cells, DNA fiber assay for fork progression, genetic epistasis\",\n      \"journal\": \"Molecular Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple domain mutants with mechanistic dissection across two bypass modes, clean genetic system\",\n      \"pmids\": [\"18498753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The Fanconi anemia (FA) core complex is required for efficient assembly of Rev1 nuclear foci (independently of FANCD2, FANCI, and PCNA monoubiquitination) and for efficient spontaneous and UV-induced point mutagenesis. Rev1 is required downstream of the FA core complex to prevent chromosomal aberrations caused by DNA crosslinkers.\",\n      \"method\": \"Complementation analysis in FA-deficient cells, immunofluorescence for Rev1 foci, mutation frequency assay, chromosomal aberration analysis\",\n      \"journal\": \"DNA Repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — foci assembly and functional assays, genetic epistasis, single lab\",\n      \"pmids\": [\"18448394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Yeast Rev1 protein interacts with yeast Pol-eta through the Rev1 polymerase-associated domain (PAD), not the C-terminus as in humans. This complex formation enhances the DNA synthesis activity of Rev1.\",\n      \"method\": \"Co-immunoprecipitation, in vitro DNA synthesis assay, domain deletion analysis\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with domain mapping and in vitro activity assay, single lab\",\n      \"pmids\": [\"17875922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Human REV1 inserts dCTP with similar catalytic efficiency (kcat/Km) opposite template G and N2-alkylguanine adducts of increasing bulk (up to N2-BPG) but is severely inhibited by O6-alkylguanine adducts. REV1 binds N2-BPG-adducted DNA ~3-fold more tightly than unmodified G-containing DNA, and the rate-limiting step is likely product release rather than chemistry opposite N2-BPG.\",\n      \"method\": \"Steady-state and pre-steady-state kinetics, elemental effect assay with purified recombinant human REV1\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — detailed kinetic characterization with multiple substrates and pre-steady-state analysis, single lab\",\n      \"pmids\": [\"18591245\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Crystal structure of yeast Rev1 in ternary complex with DNA containing an abasic (AP) lesion and dCTP reveals that the abasic lesion is driven to an extrahelical position (similar to template G) and C incorporation is mediated by the conserved Arg324 (surrogate arginine), demonstrating the same protein-template mechanism for AP site bypass.\",\n      \"method\": \"X-ray crystallography of ternary Rev1-DNA(AP)-dCTP complex\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure of ternary complex at AP site, mechanistically confirming protein-template mechanism for a second substrate\",\n      \"pmids\": [\"18275815\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The Rev1 BRCT domain of mammalian cells plays a role in early (S-phase-associated) mutagenic TLS: cells with a BRCT domain deletion are deficient in the early DNA damage bypass pathway and show reduced UV-induced mutagenesis. Rev1-deficient cells show defects in both early and late bypass pathways, with persistent gaps causing G2 arrest.\",\n      \"method\": \"Targeted deletion of BRCT domain in mouse embryonic fibroblasts, DNA replication analysis, cell cycle analysis\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — domain-specific deletion versus full knockout comparison with mechanistic pathway dissection\",\n      \"pmids\": [\"19332561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"A novel REV1-interacting region (RIR) motif containing two consecutive phenylalanines (FF motif, consensus x-x-x-F-F-y-y-y-y) present in Pol-kappa, Pol-iota, and Pol-eta is essential for binding to REV1 C-terminus. A Pol-kappa mutant lacking REV1-binding activity fails to complement genotoxin sensitivity of Polk-null cells.\",\n      \"method\": \"Yeast two-hybrid, pulldown assay, sequence alignment, functional complementation in Polk-null MEFs\",\n      \"journal\": \"Genes to Cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mutagenesis defining FF motif with in vivo functional validation, key motif conserved across polymerases\",\n      \"pmids\": [\"19170759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Yeast Rev1 promotes complex formation of Pol-zeta with the Pol32 subunit of Pol-delta: Pol32 physically interacts with Rev1 but does not directly bind Pol-zeta, and can bind the Rev1-Pol-zeta complex through Rev1. Pol32 binding does not stimulate DNA synthesis by Rev1 or Pol-zeta in this complex.\",\n      \"method\": \"Co-immunoprecipitation, in vitro pull-down, in vitro DNA synthesis assay with reconstituted complexes\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and in vitro reconstitution establishing protein interactions, single lab\",\n      \"pmids\": [\"19487673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Crystal structure of human REV1 ternary complex reveals conservation of the protein-template mechanism from yeast: template G is evicted, incoming dCTP pairs with surrogate arginine. Human REV1 has two unique inserts (I1 and I2): I1 extends >20 Å from the active site (potential platform for protein-protein interactions) and I2 acts as a flap on the hydrophobic pocket accommodating template G.\",\n      \"method\": \"X-ray crystallography of human REV1 ternary complex\",\n      \"journal\": \"Journal of Molecular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure of human REV1 ternary complex, mechanistic conservation and novel structural features identified\",\n      \"pmids\": [\"19464298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Mec1 (ATR homolog) promotes association of the Pol-zeta/Rev1 complex with double-strand breaks (DSBs) through Mec1-dependent phosphorylation. Rev1 plays a non-catalytic role in this DSB association. Rev1 association with DSBs does not require Rad24, nor Rad6-Rad18-mediated PCNA ubiquitination.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) at defined DSBs in yeast, genetic analysis\",\n      \"journal\": \"Current Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP assay with genetic dissection of requirements, single lab\",\n      \"pmids\": [\"16546083\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Crystal structure of human REV7 in complex with a REV3 fragment reveals the mechanism of REV7-REV3 interaction. The REV7-REV3 structural interface creates a binding site for REV1, explaining how REV7 acts as an adaptor protein to recruit Pol-zeta to lesion sites.\",\n      \"method\": \"X-ray crystallography of REV7-REV3 fragment complex, biochemical interaction analysis\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure with structural basis for protein interactions defined\",\n      \"pmids\": [\"20164194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Human Rev1 disrupts G-quadruplex (G4) DNA structures in vitro and prevents refolding. hRev1 binds G4 DNA substrates with 4-15-fold lower Kd than non-G4 DNA. Nucleotidyl transfer activity is not necessary for G4 unfolding. Rev1 can promote fork progression by dislodging tetrad guanines or preventing refolding.\",\n      \"method\": \"Fluorescence-based G4 disruption assay, binding affinity measurement (Kd), pre-steady-state kinetics\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro binding and unfolding assays with kinetic analysis, mutagenesis to separate catalytic from structural activity\",\n      \"pmids\": [\"24366879\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The UBM of S. cerevisiae Rev1 (second UBM) binds ubiquitin at the hydrophobic surface centered at L8 (not I44) of ubiquitin. Only the second UBM of yeast Rev1 is functional and is essential for Rev1-dependent cell survival and mutagenesis. Mutations disrupting UBM-ubiquitin interaction impair Rev1-mediated DNA damage tolerance in vivo.\",\n      \"method\": \"NMR structure of UBM-ubiquitin complex, mutagenesis of ubiquitin binding interface, in vivo mutagenesis and survival assays\",\n      \"journal\": \"Molecular Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — NMR structure combined with mutagenesis and in vivo functional validation\",\n      \"pmids\": [\"20159559\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Rev1's DNA polymerase catalytic activity is biologically significant in vivo for resistance to 4-NQO (which causes N2-dG adducts) but not to UV or cisplatin. The catalytic activity is more critical when error-free tolerance (Mms2 pathway) is disrupted.\",\n      \"method\": \"Catalytic dead Rev1 mutant in yeast, survival assays, mutation frequency assays with defined genotoxins\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined catalytic mutant with substrate-specific functional dissection, single lab\",\n      \"pmids\": [\"20980236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Crystal structure of yeast Rev1 in ternary complex with AP site-containing DNA and dCTP shows the abasic lesion in extrahelical position with C incorporation mediated by conserved Arg324, establishing a unified protein-template mechanism for both template G and AP site bypass.\",\n      \"method\": \"X-ray crystallography of ternary complex\",\n      \"journal\": \"Journal of Molecular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure with direct mechanistic insight, single lab\",\n      \"pmids\": [\"21167175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The Rev1-PCNA interaction occurs at a non-canonical binding site near the monomer-monomer interface of the PCNA trimer (via the Rev1 PAD domain), which is the same novel interface used by Pol-zeta. The pol30-113 mutation at this interface specifically disrupts the Rev1/Pol-zeta-dependent TLS pathway.\",\n      \"method\": \"GST pull-down, affinity bead pull-down, gel filtration, genetic epistasis analysis\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical methods identifying non-canonical PCNA binding with genetic validation, single lab\",\n      \"pmids\": [\"21799021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The BRCT region of Rev1 (via an extra α-helix N-terminal to the BRCT domain) specifically binds 5'-phosphorylated recessed primer-template junctions. Rev1 also binds recessed 3' primer-template junctions. These dual DNA binding characteristics are proposed to mediate recruitment of Rev1 downstream of stalled forks.\",\n      \"method\": \"In vitro DNA binding assays with purified mouse and yeast Rev1, domain deletions\",\n      \"journal\": \"DNA Repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding assays with domain analysis, single lab\",\n      \"pmids\": [\"21752727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The dCMP transferase catalytic activity of Rev1 is biologically relevant and required specifically for dCMP insertion during bypass of endogenously generated AP sites (from uracil excision) in yeast chromosomal DNA. Loss of Rev1 catalytic activity allows insertion of dGMP or dTMP, indicating that Rev1 catalysis is the primary determinant of C insertion opposite AP sites in vivo.\",\n      \"method\": \"Frameshift- and nonsense-reversion assays in yeast using catalytic-dead Rev1 mutant\",\n      \"journal\": \"DNA Repair\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — sensitive in vivo genetic assay with catalytic mutant, two orthogonal reversion assays, single lab\",\n      \"pmids\": [\"22024240\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Human REV1, REV3, and REV7 interact in vivo (by co-immunoprecipitation) and together promote homologous recombination repair of DSBs. REV1, REV3, or REV7-depleted cells show increased chromosomal aberrations, residual DSBs, and defects in HR repair after ionizing radiation. Pol-eta and RAD18-dependent PCNA monoubiquitination are not required for this DSB repair function.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, chromosomal aberration analysis, γH2AX foci, HR assay\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple knockdowns with orthogonal readouts establishing HR role, single lab\",\n      \"pmids\": [\"21926160\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"FAAP20, an integral subunit of the FA core complex, contains a UBZ4 domain that binds monoubiquitinated Rev1. FAAP20 binding stabilizes Rev1 nuclear foci and promotes interaction of the FA core with PCNA-Rev1 DNA damage bypass complexes. This provides a mechanistic link between the FA core complex and TLS polymerase activity.\",\n      \"method\": \"Identification of FAAP20 as FA core component, co-immunoprecipitation, domain analysis, immunofluorescence for Rev1 foci\",\n      \"journal\": \"Nature Structural & Molecular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP, domain analysis, direct interaction characterization with functional consequence (foci stability), single lab but comprehensive\",\n      \"pmids\": [\"22266823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Crystal structure of the quaternary translesion polymerase complex consisting of the Rev1 CTD, heterodimeric Pol-zeta (Rev7/Rev3-RBM), and Pol-kappa RIR reveals that the Rev1 CTD serves as a scaffold with two distinct surfaces: one for Rev7 binding (at α2-α3 loop and α3) and one for RIR binding (creating a hydrophobic cavity for FF residues). This provides the molecular basis for Rev1 as a scaffold bridging insertion and extension polymerases.\",\n      \"method\": \"Protein purification, X-ray crystallography, yeast two-hybrid to validate interface residues\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure of quaternary complex with biochemical validation of interface\",\n      \"pmids\": [\"22859295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Crystal structure of human REV1 CTD-REV7-REV3 fragment ternary complex reveals that the Rev1 CTD adopts a four-helix bundle interacting with REV7 via a conserved linker between helices 2 and 3, at a site distinct from the Pol-eta/kappa binding site. REV7 acts as an adaptor recruiting Pol-zeta to stalled forks via Rev1-REV7 interaction.\",\n      \"method\": \"X-ray crystallography, co-immunoprecipitation, cellular survival assays\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with interface distinct from previously known binding surface, functional validation\",\n      \"pmids\": [\"22859296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NMR solution structure of mouse Rev1 CTD reveals an atypical four-helix bundle. Two distinct surfaces of the Rev1 CTD mediate Rev7 binding (centered at α2-α3 loop and N-terminal α3) and Pol-kappa RIR binding (FF residues binding in a deep hydrophobic cavity). Binding of Pol-kappa RIR induces folding of the disordered RIR into a three-turn α-helix and induces formation of a β-hairpin in the Rev1 CTD N-terminal loop.\",\n      \"method\": \"NMR solution structure determination, yeast two-hybrid, binding affinity measurements\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — NMR structure with biochemical validation of two distinct binding interfaces\",\n      \"pmids\": [\"22700975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NMR structure of human Rev1 CTD and its complex with Pol-eta RIR shows the four-helix bundle with β-hairpin; free Rev1-CT and the Rev1-CT/Pol-eta-RIR complex exhibit μs-ms conformational dynamics at the RIR binding site that may facilitate polymerase exchange.\",\n      \"method\": \"NMR structure determination, NMR spin-relaxation and relaxation dispersion measurements\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure with dynamic characterization, single lab\",\n      \"pmids\": [\"22691049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Rev1 directly interacts with Ung (uracil DNA glycosylase) and targets Ung to switch regions during class switch recombination (CSR) in an AID-dependent manner. Rev1-deficient B cells show reduced Ung recruitment to S regions, decreased DNA-dU glycosylation, and reduced CSR. Rescue of CSR by catalytically inactive Rev1 shows this function is mediated by Rev1 scaffolding, not enzymatic activity.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, CSR assays in Rev1-/- B cells, complementation with catalytic mutant\",\n      \"journal\": \"Cell Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP identifying novel binding partner, functional rescue distinguishing catalytic vs. scaffolding role\",\n      \"pmids\": [\"23140944\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Rev1 is required for efficient point mutagenesis (insertion/deletion) at BPDE-dG in mammalian cells, specifically for mutagenic TLS. The Rev1 C-terminus is required; yeast and mammalian three-hybrid assays confirmed REV7 mediates REV3-Rev1 C-terminus interaction, supporting Rev1 recruiting Pol-zeta through REV7.\",\n      \"method\": \"Single lesion plasmid TLS assay in Rev1-/- MEFs, complementation with C-terminal deletion mutant, yeast/mammalian three-hybrid assay\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — functional TLS assay with specific mutants and interaction mapping in multiple systems\",\n      \"pmids\": [\"22303021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"REV7 is required for APC/CDH1- and APC/CDC20-mediated polyubiquitination and proteasomal degradation of REV1. REV7 binds to an N-terminal region of REV1 that contains both the APC degron and an additional REV7-binding domain. Depletion of REV7 stabilizes REV1 by preventing polyubiquitination.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, siRNA knockdown, overexpression of APC co-activators\",\n      \"journal\": \"Cell Cycle\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple protein interaction and functional assays, single lab\",\n      \"pmids\": [\"23287467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NMR mapping shows that the Rev1 BRCT domain of S. cerevisiae directly interacts with PCNA in solution. The PCNA-binding interface of the Rev1-BRCT domain comprises conserved residues of the outer α1-helix surface and flanking loops. Rev1-BRCT binds the inter-domain region of PCNA that overlaps with the PIP-box binding site; Rev1-BRCT and Pol-eta PIP-box interactions with the same PCNA monomer are mutually exclusive.\",\n      \"method\": \"Solution NMR structure of Rev1-BRCT, TROSY NMR binding analysis with 87 kDa PCNA, competition with PIP-box peptide\",\n      \"journal\": \"Journal of Molecular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure with direct binding characterization and competition experiment, single lab\",\n      \"pmids\": [\"23747975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"REV1-deficient cells are compromised in replicating G-quadruplex (G4)-forming DNA, leading to stochastic loss of parental histone marks (H3K4me3, H3K9/14ac) and changes in gene expression. A single G4 motif on the leading strand template is responsible for this epigenetic instability at the BU-1 locus, with effects depending on the G4's distance from the TSS.\",\n      \"method\": \"Gene disruption in DT40 cells, ChIP for histone marks, gene expression analysis, G4 motif mutagenesis\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic disruption with mechanistic dissection of G4 position requirements, single lab\",\n      \"pmids\": [\"25190518\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Rev1-Pol-zeta complex recruitment to interstrand crosslink (ICL) sites requires the Fanconi anemia core complex but not FancI-FancD2. The extension step of ICL bypass involves a Rev1-Pol-zeta complex. Deep sequencing shows ICL repair introduces a short mutagenic tract with ~1% maximum mutation frequency.\",\n      \"method\": \"Site-specific ICL in Xenopus egg extracts, deep sequencing of repair products, immunodepletion experiments\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted cell-free system with site-specific lesion, genetic depletion, and deep sequencing of repair products\",\n      \"pmids\": [\"26071591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Rev1 is targeted to laser-induced DNA damage in a manner dependent on its ubiquitin-binding motifs (UBMs), RAD18, and monoubiquitinated FANCD2 (FANCD2-mUb) which associates with REV1. Expression of FANCD2-Ub chimera in RAD18-depleted cells enhances REV1 assembly at damage sites. REV1 also protects nascent replication tracts from degradation by stabilizing RAD51 filaments.\",\n      \"method\": \"Laser microirradiation and immunofluorescence, co-immunoprecipitation, DNA fiber assay\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiments with genetic dissection of requirements, RAD51 fiber protection assay, single lab\",\n      \"pmids\": [\"26187992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In human and mouse cells, Rev1 is indispensable for TLS mediated by Pol-eta, Pol-iota, and Pol-kappa opposite UV lesions, but is not required for Pol-zeta-dependent TLS. Rev1 promotes predominantly error-free TLS opposite UV lesions in humans, acting as an indispensable scaffolding component for Y-family polymerases.\",\n      \"method\": \"siRNA/gene knockout in human and mouse fibroblasts, single lesion plasmid TLS assay\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — systematic depletion of multiple polymerases with defined lesion bypass assay, distinguishes human from yeast function\",\n      \"pmids\": [\"26680302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PolD3, a subunit of the four-subunit Pol-zeta complex, contains an RIR motif whose interaction with Rev1-CT is among the tightest mediated by RIR motifs. NMR structure of Rev1-CT/PolD3-RIR complex reveals structural basis for high affinity. This suggests a mechanism for polymerase switching: PolD3-RIR binding to Rev1-CT displaces inserter polymerases and facilitates assembly of the full Pol-zeta extender complex.\",\n      \"method\": \"NMR structure determination of Rev1-CT/PolD3-RIR complex, binding affinity measurements\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure with quantitative binding affinity data, mechanistic polymerase switch model supported\",\n      \"pmids\": [\"26982350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Budding yeast Rad5 physically interacts with Rev1 via an RFF motif in the Rad5 N-terminus that binds a hydrophobic pocket within the Rev1 CTD. Crystal structure of the Rad5-Rev1 interaction was determined. Rad5's TLS function (via Rev1 recruitment) and its error-free DDT function (via E3 ligase) are separable. Disrupting the Rev1-Rad5 interaction inactivates Rev1's non-catalytic TLS function.\",\n      \"method\": \"Domain mapping, crystal structure of Rad5-Rev1 interaction, genetic separation-of-function analysis\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure with functional genetic validation, single lab\",\n      \"pmids\": [\"27001510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"REV1 promotes PCNA monoubiquitylation after UV radiation by interacting with ubiquitylated RAD18, which facilitates release of non-ubiquitylated RAD18 from ubiquitylated RAD18 trapping and allows RAD18 chromatin recruitment. This stimulatory effect also occurs after hydroxyurea and mitomycin C treatment but not MMS.\",\n      \"method\": \"Co-immunoprecipitation, PCNA ubiquitylation assay, chromatin fractionation\",\n      \"journal\": \"Journal of Cell Science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP identifying novel interaction and biochemical stimulation assay, single lab\",\n      \"pmids\": [\"26795561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The PIP motif of yeast Pol-eta mediates interactions with both PCNA and Rev1 CTD, binding in the hydrophobic pocket of the Rev1 C-terminal domain. RIR motifs of human Pol-kappa and PIP motifs of yeast Msh6 can also bind both PCNA and Rev1, demonstrating overlapping specificities of PIP and RIR motifs.\",\n      \"method\": \"Binding assays, fluorescence polarization, yeast two-hybrid, mutagenesis\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple binding assays with multiple proteins, single lab\",\n      \"pmids\": [\"26903512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Rev7 dimerizes (homodimer) when tethered by the two Rev7-binding motifs (RBMs) in Rev3, using the conventional HORMA dimerization interface. The Rev7 dimer can bind only one copy of Rev1, revealing an unexpected 1:2:1 Rev1:Rev7:Rev3 architecture. Rev7 also heterodimerizes with Mad2 and p31comet. Mutation of the Rev7 dimer interface increases cellular sensitivity to DNA damage.\",\n      \"method\": \"In vitro structural analysis, biochemical interaction studies, functional assay in Rev7-/- cells\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — combination of structural and biochemical analysis with in vivo functional validation\",\n      \"pmids\": [\"30111544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Starvation induces SUMO2/3 modification (SUMOylation) of REV1, which relieves REV1's inhibition of p53, enhancing p53-dependent proapoptotic gene expression and apoptosis in cancer cells. REV1 is a novel binding partner of tumor suppressor p53 and regulates its activity.\",\n      \"method\": \"Co-immunoprecipitation (REV1-p53 interaction), SUMOylation assay, gene expression analysis, apoptosis assay\",\n      \"journal\": \"Cancer Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — novel protein interaction identified by Co-IP with functional consequence for p53 activity, single lab\",\n      \"pmids\": [\"25614517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Hsp90 binds REV1 in vivo and in vitro. Inhibition of Hsp90 reduces REV1 protein levels through proteasomal degradation, suppresses UV-induced mutagenesis, disrupts the interaction between REV1 and monoubiquitinated PCNA, and suppresses UV-induced REV1 focus formation. Hsp90 promotes correct folding of REV1 to enable its interaction with monoubiquitinated PCNA.\",\n      \"method\": \"Co-immunoprecipitation (in vivo and in vitro), Hsp90 inhibitor treatment, immunofluorescence for foci, mutagenesis assay\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with functional dissection using specific inhibitor, single lab\",\n      \"pmids\": [\"21690293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"REV1-Pol-zeta (inhibited by small molecule JH-RE-06) maintains viability of BRCA1/2-deficient cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps. Gap accumulation requires SMUG1 glycosylase and is exacerbated by RAD18 depletion or REV1-Pol-zeta inhibition. JH-RE-06 is preferentially toxic toward HR-deficient cancer cells and acts additively with crosslinking agents or PARP inhibitors.\",\n      \"method\": \"DNA fiber analysis, electron microscopy, small molecule inhibitor (JH-RE-06), siRNA knockdown, mouse xenograft models\",\n      \"journal\": \"Molecular Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (EM, DNA fiber, genetics, in vivo models) establishing pathway position\",\n      \"pmids\": [\"34508659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Human REV1 has a higher affinity for single-stranded DNA (ssDNA) than for primer termini, targeting it to included primer termini. This property requires the N- and C-terminal domains (the catalytic core alone loses this function). This distinguishes REV1 from other DNA polymerases including Pol-alpha, Pol-beta, and Pol-eta.\",\n      \"method\": \"In vitro DNA binding assays with purified human REV1 and deletion mutants\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding assay with domain deletion analysis, single lab\",\n      \"pmids\": [\"16803901\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"REV1 is a specialized Y-family DNA polymerase that operates via a unique protein-template mechanism—evicting the templating base from the helix and pairing incoming dCTP with a conserved surrogate arginine (Arg324)—to insert dCMP opposite template G, abasic sites, and numerous N2-guanine adducts; beyond this catalytic role, REV1 serves as an essential scaffolding protein whose C-terminal domain (a four-helix bundle) simultaneously coordinates polymerase switching by binding Rev7 (and thus Pol-zeta) and the FF-containing RIR/PIP motifs of Y-family insertion polymerases (Pol-eta, -iota, -kappa), while its N-terminal BRCT domain mediates PCNA binding and early TLS, its UBMs recruit it to monoubiquitinated PCNA and FANCD2, and its cell-cycle-regulated expression (peaking in G2/M) and post-translational modifications (phosphorylation, SUMOylation, APC/REV7-dependent degradation, Hsp90-dependent folding) control the timing and magnitude of mutagenic translesion synthesis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"REV1 is a specialized Y-family DNA polymerase and central scaffolding protein of the translesion synthesis (TLS) machinery that enables cells to tolerate DNA damage at the cost of mutagenesis [#0, #7, #54]. As an enzyme, REV1 is a template-independent deoxycytidyl (dCMP) transferase that inserts dCMP opposite template guanine, abasic sites, and a range of N2-guanine minor-groove adducts [#0, #1, #26]. Crystal structures of yeast and human ternary complexes establish its unique protein-template mechanism: the templating base (or abasic lesion) is evicted from the helix and incoming dCTP is paired not with the template but with a conserved surrogate arginine (Arg324) [#10, #27, #31]. This catalytic activity is biologically relevant chiefly for accurate C insertion opposite endogenous abasic sites and N2-dG adducts [#36, #40]. Beyond catalysis, REV1's principal in vivo role is as a non-catalytic scaffold: its C-terminal four-helix-bundle domain simultaneously binds Rev7 (recruiting Pol-zeta) and the FF-containing RIR/PIP motifs of the insertion polymerases Pol-eta, Pol-iota, and Pol-kappa, thereby coordinating the polymerase switch between insertion and Pol-zeta-mediated extension [#6, #29, #43, #45]. REV1 is recruited to damage sites through its BRCT domain, which binds PCNA and 5'-phosphorylated recessed primer-template junctions, and through C-terminal ubiquitin-binding motifs (UBMs) that engage monoubiquitinated PCNA and FANCD2 [#15, #16, #35, #53]. This recruitment couples REV1 to the Rad6/Rad18-PCNA-ubiquitination axis and to the Fanconi anemia pathway during interstrand crosslink repair [#12, #42, #52]. REV1 expression and activity are tightly controlled across the cell cycle by peak G2/M abundance, MEC1/ATR-dependent phosphorylation, Hsp90-dependent folding, and APC/REV7-dependent degradation [#17, #18, #49, #61]. Functionally, REV1 is required for damage-induced point mutagenesis, immunoglobulin gene diversification and class switch recombination, replication through G-quadruplex structures, and the mutagenic filling of PRIMPOL-dependent ssDNA gaps that sustains viability of HR-deficient cancer cells [#7, #47, #51, #62].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established REV1's defining biochemical activity, answering what reaction the protein catalyzes: a template-dependent dCMP transferase that acts opposite abasic sites and guanine.\",\n      \"evidence\": \"In vitro dCMP transferase assay with purified yeast Rev1; conserved in purified human REV1\",\n      \"pmids\": [\"8751446\", \"10536157\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish the structural basis for dCMP selectivity\", \"In vivo relevance of catalysis versus scaffolding unresolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Quantitative kinetics defined REV1 as a low-processivity, G-template-specific polymerase, clarifying that its insertion fidelity is biased toward C opposite G rather than broad lesion bypass.\",\n      \"evidence\": \"Steady-state kinetics of nucleotide incorporation by purified yeast Rev1 across multiple substrates\",\n      \"pmids\": [\"11850424\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve whether catalytic insertion or structural roles dominate at abasic sites in vivo\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Genetic and reconstitution analysis indicated that at abasic sites REV1's predominant contribution is structural rather than catalytic, reframing it as a pathway organizer alongside Pol-delta and Pol-zeta.\",\n      \"evidence\": \"Genetic epistasis plus in vitro reconstitution and kinetics in yeast\",\n      \"pmids\": [\"11316789\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural role mechanism not defined at molecular level\", \"Did not identify the scaffolding interactions later mapped\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identified REV1's scaffolding function by showing its C-terminus binds Pol-eta, -iota, -kappa, and Rev7 (Pol-zeta) at a common ~100-residue region, with Rev7 competing for binding — establishing REV1 as a polymerase-bridging hub.\",\n      \"evidence\": \"Co-IP, GST pulldown, and competition assays with mouse Rev1 and partner polymerases; loss-of-function in DT40 cells\",\n      \"pmids\": [\"14657033\", \"12660171\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of simultaneous versus competitive binding not yet resolved\", \"Recruitment to lesions not yet mechanistically defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defined the recruitment logic: REV1's BRCT domain and C-terminal UBMs bind PCNA and monoubiquitinated PCNA respectively, coupling REV1 to the Rad18/PCNA-ubiquitination damage signal and to replication foci.\",\n      \"evidence\": \"Domain mutagenesis, Co-IP, foci imaging in DT40/mouse cells; in vitro TLS activation by ubiquitinated PCNA\",\n      \"pmids\": [\"15741181\", \"16857592\", \"16982685\", \"16344468\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Temporal coordination of BRCT versus UBM recruitment not resolved\", \"Structural detail of UBM-ubiquitin contact pending\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Crystal structures of yeast Rev1 ternary complexes solved the central mechanistic question of nucleotide selection, revealing a protein-template mechanism with base eviction and Arg324 as a surrogate templating residue.\",\n      \"evidence\": \"X-ray crystallography of Rev1-DNA-dCTP ternary complexes at template G and abasic sites; conserved in human REV1 structure\",\n      \"pmids\": [\"16195463\", \"18275815\", \"21167175\", \"19464298\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address how scaffolding CTD is positioned relative to catalytic core\", \"Conformational dynamics during base eviction not captured\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Pinpointed the UBM-ubiquitin interface by mutagenesis and NMR, showing UBM contacts are required for damage-induced mutagenesis and survival, linking ubiquitin recognition to function.\",\n      \"evidence\": \"Mutational analysis, in vitro binding to ubiquitinated PCNA, NMR of UBM-ubiquitin complex, in vivo mutagenesis in yeast\",\n      \"pmids\": [\"17517887\", \"20159559\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How UBM engagement is regulated during the cell cycle not defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined the FF-containing RIR motif as the shared docking signal in Pol-eta/-iota/-kappa for the REV1 CTD, explaining how REV1 selects insertion polymerases.\",\n      \"evidence\": \"Yeast two-hybrid, pulldown, sequence alignment, and complementation in Polk-null MEFs\",\n      \"pmids\": [\"19170759\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish how competing RIR/Rev7 interactions are temporally ordered\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Structures of the REV1 CTD four-helix bundle in complex with Rev7/Rev3 and RIR peptides resolved how REV1 simultaneously engages extension (Pol-zeta) and insertion polymerases via two distinct surfaces, providing the molecular basis for polymerase switching.\",\n      \"evidence\": \"X-ray crystallography of quaternary and ternary complexes and NMR of mouse/human CTD with conformational dynamics analysis\",\n      \"pmids\": [\"22859295\", \"22859296\", \"22700975\", \"22691049\", \"22303021\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Order of polymerase exchange events not directly observed\", \"Coupling of CTD switching to the catalytic core unresolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Connected REV1 to the Fanconi anemia pathway and to antibody diversification, showing FAAP20 binds monoubiquitinated Rev1 and that Rev1 scaffolds Ung to switch regions during class switch recombination independent of catalysis.\",\n      \"evidence\": \"Co-IP, ChIP, domain analysis, foci imaging, and catalytic-mutant rescue in B cells\",\n      \"pmids\": [\"22266823\", \"23140944\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanistic link between FA recruitment and TLS polymerase loading incompletely defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Refined the polymerase-switch model by showing PolD3-RIR binds the REV1 CTD with high affinity and that PIP and RIR motifs have overlapping specificities, suggesting how the full Pol-zeta extender is assembled after inserter displacement.\",\n      \"evidence\": \"NMR structures and binding-affinity measurements of Rev1-CT complexes with PolD3-RIR and PIP/RIR peptides\",\n      \"pmids\": [\"26982350\", \"26903512\", \"27001510\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinetics of switch in the context of an active replication fork not measured\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Established that human REV1 is an indispensable scaffold for Y-family-mediated, predominantly error-free TLS opposite UV lesions, distinguishing its mammalian function from yeast and from Pol-zeta-dependent bypass.\",\n      \"evidence\": \"Systematic siRNA/knockout of multiple polymerases with single-lesion plasmid TLS assays in human and mouse cells\",\n      \"pmids\": [\"26680302\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of catalytic versus scaffolding REV1 to error-free bypass not fully partitioned\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Revealed a replication-fidelity role beyond classical lesion bypass: REV1 is required to replicate G-quadruplex DNA, and its loss causes stochastic loss of parental histone marks and epigenetic instability.\",\n      \"evidence\": \"In vitro G4 unfolding/binding assays and DT40 knockout with ChIP for histone marks and G4-motif mutagenesis\",\n      \"pmids\": [\"24366879\", \"25190518\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether G4 resolution at forks uses the same recruitment machinery as lesion TLS is unclear\", \"Single-locus mechanism not generalized genome-wide\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Positioned REV1-Pol-zeta in the mutagenic filling of PRIMPOL-dependent ssDNA gaps, defining a vulnerability of HR-deficient cancer cells and validating a small-molecule inhibitor (JH-RE-06).\",\n      \"evidence\": \"DNA fiber, electron microscopy, knockdown, inhibitor treatment, and xenograft models\",\n      \"pmids\": [\"34508659\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Substrate scope of gap-filling beyond BRCA-deficient context not defined\", \"How gap-filling integrates with cell-cycle-regulated REV1 abundance unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How REV1's catalytic core, its scaffolding CTD, and its multiple regulatory inputs (phosphorylation, SUMOylation, Hsp90 folding, APC/REV7 degradation) are integrated into a single dynamic complex that orders insertion, switching, and extension at a fork remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structure of full-length REV1 with both catalytic and scaffolding modules engaged\", \"Quantitative timing of polymerase exchange in vivo not measured\", \"Regulatory crosstalk among PTMs not mechanistically connected\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [0, 1, 4, 10, 26, 27, 31, 40]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 4, 26]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [4, 34, 39, 63]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [6, 29, 43, 45, 47]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [15, 16, 22, 24]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [18, 32]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [7, 23, 52, 54]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [12, 23, 62]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [24, 42, 52, 62]}\n    ],\n    \"complexes\": [\n      \"REV1-Pol-zeta (REV1-REV7-REV3) translesion polymerase complex\",\n      \"REV1-REV7 heterodimer\"\n    ],\n    \"partners\": [\n      \"REV7\",\n      \"REV3\",\n      \"POLH\",\n      \"POLK\",\n      \"POLI\",\n      \"PCNA\",\n      \"FAAP20\",\n      \"FANCD2\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}